Skip to main content
PLOS One logoLink to PLOS One
. 2023 Oct 16;18(10):e0293028. doi: 10.1371/journal.pone.0293028

The effect of health behavior interventions to manage Type 2 diabetes on the quality of life in low-and middle-income countries: A systematic review and meta-analysis

Ashmita Karki 1,*, Corneel Vandelanotte 1, Saman Khalesi 1, Padam Dahal 1, Lal B Rawal 1,2
Editor: Edward Zimbudzi3
PMCID: PMC10578590  PMID: 37844107

Abstract

Background

Behavioral interventions targeted at managing Type 2 diabetes mellitus (T2DM) may have a positive effect on quality of life (QOL). Limited reviews have synthesized this effect in low- and middle-income countries (LMICs). This review and meta-analysis synthesised available evidence on the effect of behavioral interventions to manage T2DM on the QOL of people with T2DM in LMICs.

Methods

Electronic databases PUBMED/MEDLINE, SCOPUS, CINAHL, Embase, Web of Science and PsycINFO were searched from May to June 2022. Studies published between January 2000 and May 2022, conducted in LMICs using randomized controlled trial design, using a health behavior intervention for T2DM management, and reporting QOL outcomes were included. Difference in QOL change scores between the intervention and control group was calculated as the standardized mean difference (SMD) of QOL scores observed between the intervention and control groups. Random-effects model was used for meta-analysis.

Results

Of 6122 studies identified initially, 45 studies met the inclusion criteria (n = 8336). Of them, 31 involved diabetes self-management education and 14 included dietary and/or physical activity intervention. There was moderate quality evidence from the meta-analysis of mean QOL (n = 25) that health behavior intervention improved the QOL of people with T2DM (SMD = 1.62, 95%CI = 0.65–2.60 I2 = 0.96, p = 0.001). However, no significant improvements were found for studies (n = 7) separately assessing the physical component summary (SMD = 0.76, 95%CI = -0.03–1.56 I2 = 0.94, p = 0.060) and mental component summary (SMD = 0.43, 95%CI = -0.30–1.16 I2 = 0.94, p = 0.249) scores. High heterogeneity and imprecise results across studies resulted in low to moderate quality of evidence.

Conclusion

The findings suggest that health behavior interventions to manage T2DM may substantially improve the QOL of individuals with T2DM over short term. However, due to low to moderate quality of evidence, further research is required to corroborate our findings. Results of this review may guide future research and have policy implications for T2DM management in LMICs.

Introduction

Type 2 diabetes mellitus (T2DM) accounts for around 90% of all cases of diabetes worldwide and is associated with poor health behaviors [1]. More than half a billion people are living with diabetes globally, 75% of whom live in low-and middle-income countries (LMICs) and this number is expected to reach 783 million by 2045 [2]. In addition, people living with T2DM are known to have lower quality of life (QOL) and more depressive symptomatology than healthy people [3]. Behavioral interventions such as diabetes self-management education (DSME), diet and/or physical activity interventions may have a significant impact on diabetes care and improving one’s QOL [4]. In light of this, the aim of behavioral interventions has extended from just metabolic control to patient-oriented outcomes such as QOL [5,6]. This is particularly important because the use of QOL as an intervention outcome was found to empower people with T2DM to express their opinion on how the disease and the intervention affects their health and to take ownership of their care [7]. Furthermore, improved QOL is significantly associated with improved diabetes self-management as shown by a review of studies mostly conducted in high income countries (HICs) [5].

As a key element in chronic care, DSME has been found effective in improving metabolic control [8], behavioral outcomes [9], and QOL [10,11]. Previous reviews from LMICs have shown the effectiveness of DSME on metabolic parameters [6,12], however, outcomes in relation to QOL are inconclusive due to limited data availability on QOL outcomes [13]. This paucity of data due to the complex construct of QOL combined with likely measurement error makes the assessment of QOL quite challenging [14]. A review of twelve studies, conducted in four LMICs and two HICs indicated that DSME interventions were effective in improving clinical parameters as well as patient-reported outcomes such as self-management behavior, QOL and self-efficacy [15]. Similarly, another review of eight studies, conducted in five HICs and three LMICs demonstrated QOL improvement in 3 out of the 5 randomized controlled trials (RCTs) that reported change in QOL measures [16]. However, these reviews only included studies with DSME components, and excluded studies solely focussing on other health behavior interventions such as structured dietary and/or exercise programs. In addition, these reviews have not been synthesized to produce a pooled estimate of the effect size, which is critical to strengthen the existing evidence base. Moreover, there is a dearth of reviews exclusively focusing on LMICs.

Similarly, dietary and physical activity interventions have shown to reduce glycated haemoglobin (HbA1c) [17,18], including a recent meta-analysis showing that moderate to vigorous intensity aerobic physical activity for thirty minutes per week is significantly associated with HbA1c reduction [19]. However, reviews and meta-analyses have mainly reported on the metabolic markers in terms of outcome, rather than on psychological and QOL outcomes [20], due to the limited data available and challenges in calculating effect sizes due to using different QOL measurement tools [6]. Moreover, these studies have largely been conducted in high income countries, creating the need for reviews focusing on T2DM in LMICs.

In sum, studies worldwide have shown that health behavior interventions are effective in optimising glycemic control and diabetes management [12,19]. However, despite QOL being an important measure in T2DM management, the synthesis of evidence on the effect of these interventions on the QOL of people with T2DM in LMICs is limited. Furthermore, to our knowledge, no systematic review and meta-analysis has ever been conducted to synthesize available evidence on the effect of health behavior interventions to manage T2DM on the QOL of people in LMICs [12]. The evidence generated from this study can be used to help guide future research and clinical practice and may have policy implications in the management of T2DM in LMICs.

Methods

Reporting and registration of the review

This systematic review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guideline [21] and followed the Joanna Briggs Institute (JBI) systematic review methodology [22]. The review protocol was registered in the PROSPERO International Prospective Register of systematic reviews (Registration ID CRD42022323184) on 05 July 2022. Ethical approval was not required for conducting this systematic review and meta-analysis.

Data sources and searches

Data were searched from 26 May to 1 June 2022. Online databases PUBMED/MEDLINE, SCOPUS, CINAHL, Embase, Web of Science and PsycINFO were searched using the pre-defined search terms, which were based on the PICOS (population, intervention, comparison, outcome, and study design) framework. The population group was people with T2DM; intervention was any health behavioural intervention targeted at T2DM management; comparison group was usual care, waitlist or attentional control group; and study design was randomized controlled trial. A manual search of reference lists of included studies was also conducted to identify additional studies that met the inclusion criteria. A detailed list of search terms was developed using the combinations of mainly four key words, “Type 2 diabetes mellitus”, “Quality of life”, “Health behavior interventions” and “Randomized controlled trials”. The search terms can be seen in S1 Table. Studies were searched regardless of the location/region, then segregated by income region, rather than using the search terms for LMICs, as not all studies conducted in LMICs might have identified themselves as such. A university research librarian was consulted to optimise the search strategy.

Inclusion and exclusion criteria

Only studies with an RCT design were included in this review to ensure that the evidence provided on the effectiveness of interventions was robust. When multiple articles from the same study/studies were found, only the article that reported the most relevant QOL information/outcome was included. All types of health behavior interventions were included regardless of the setting. Only studies conducted between January 2000 and May 2022 and published in English language were included in the review, as examining QOL in individuals with T2DM is a relatively new concept. Studies were included if they 1) examined any behavioral or educational interventions targeted at improving T2DM management among people with new or established diagnosis of T2DM; 2) reported QOL outcomes using validated QOL measures, both pre- and post-intervention, as a primary or secondary outcome; 3) were conducted within an RCT design; and 4) were conducted in LMICs, as defined by the World Bank [23]. Studies were excluded if they 1) were published in languages other than English; 2) had therapeutic or pharmacological intervention strategies; 3) had mixed study population of Type 1 and 2 diabetes with no separate data reported for T2DM population; 4) were observational studies or reported in reviews, editorials, theses, books, short communication; or 5) presented inadequate or unclear QOL data.

Study selection

The articles retrieved from the search were exported to COVIDENCE [24], a web-based software developed to streamline systematic review process on 2 June 2022. After removing duplicates, title and abstract of the identified studies were independently screened by two reviewers (AK and PD) based on pre-defined inclusion criteria. Full texts of retrieved studies were then screened by two reviewers (AK and PD) independently. Any disagreements were resolved through consultation with other team members. All studies excluded at the full-text stage were recorded with detailed reasons of exclusion during screening. The study selection was completed on 22 July 2022. A PRISMA flow diagram is shown in Fig 1.

Fig 1. Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) flow diagram.

Fig 1

Outcome measures

The primary outcome measure of this review was difference in QOL change scores between the intervention and control groups. The secondary outcomes were HbA1c, fasting blood glucose (FBG), diabetes self-management behavior, and anthropometric measures such as BMI and weight.

Data extraction

Author name, publication year, study objective, country, setting, study design, demographic characteristics such as age, gender, etc., intervention description, control details, duration of intervention and follow up, QOL measurement tools, and primary and secondary intervention outcomes of interest were extracted using a template by one author (AK) and their accuracy were checked by the second author (PD) [25] from 23 July to 25 August 2022.

Quality assessment

The 13-item JBI Critical Appraisal Checklist for Randomized Controlled Trials was used to assess methodological quality of the selected studies [26]. Two reviewers (AK and PD) independently assessed the risk of bias. Any disagreements were discussed with the team members until consensus was reached. Each item in the JBI checklist was scored one if they fulfilled the criteria for that item and scored zero if they did not fulfil the criteria. For example, if a study reported blinding of outcome assessors, then the study was scored ‘1’ for the item about blinding of outcome assessors, whereas, if the study did not report blinding of outcome assessors, then the study was scored ‘0’. Summary scores were obtained for each selected studies by adding the item-specific scores. The quality of the studies was then rated as good (≥8), fair (6–7), or poor (≤5) based on the summary scores [27]. In addition, the quality of evidence across RCTs included in the meta-analysis was assessed by two reviewers (AK and PD) using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, and rated as high, moderate, low or very low [28]. Since all included studies were RCTs, the rating began with a high-certainty rating. Then, the quality was upgraded or downgraded based on the following criteria: i) quality across the studies as determined by the JBI Critical Appraisal Checklist for Randomized Controlled Trials; ii) inconsistency/heterogeneity level; iii) indirectness of evidence; iv) imprecise results (wide 95% CI i.e., > 0.8 SMD); and v) publication bias (visual inspection of funnel plot) [29]. If the majority of the RCTs scored ≤ 5 on the JBI scale, the certainty of evidence was downgraded two places whereas, if the effect size was large (SMD ≥ 0.8), then the evidence was upgraded one place [29].

Data synthesis and analysis

Given the number of different scales used to measure QOL scores, the effect of T2DM health behavior interventions was calculated as the standardized mean difference (SMD) of QOL change scores observed between the intervention and control groups. The Cochrane Handbook for Systematic Review of Interventions guidelines [30] was followed to calculate mean and standard deviation (SD) of change from baseline in the intervention and control groups. Given that none of the studies included in the meta-analysis reported the absolute mean and SD of change, a correlation coefficient (r) of 0.6 was assumed [30] to calculate the SD of change using the following formula:

SDChange=SDBaseline2+SDFinal2(2×r×SDBaseline×SDFinal)

QOL score was reported as overall QOL score in majority of the studies. Physical component summary (PCS) and/or mental component summary (MCS) scores were also reported in some studies that used Short Form (SF) questionnaires to measure QOL. Therefore, three separate meta-analyses were performed to investigate the effect of health behavior intervention on overall, PCS, or MCS scores. The magnitude of effect of the behavior interventions on QOL was defined according to Cohen recommendation on Hedge’s g levels and interpreted as small (g ≤ 0.2), medium (g = 0.2 to 0.5), and high (g≥ 0.8) effect [31]. Heterogeneity was assessed using Cochran’s I2 index with values <40, 40–75, and >75% corresponded to low, moderate and high heterogeneity respectively [30]. Similarly, funnel plots were used to assess publication bias. Given the heterogeneous nature of the interventions and QOL measurement tools used, a random-effects model was applied to assess the mean and variability of effect sizes across studies. For studies with QOL measurements at multiple time-points, only the measurements at baseline and following intervention completion (post-intervention) were included in the meta-analysis to maintain consistency across studies using a similar timepoint and improve homogeneity in data extraction.

Subgroup analyses were performed to investigate differences in the effect of behavior change intervention on QOL scores based on intervention type (DSME, diet and/or physical activity interventions), settings (hospital/diabetes clinic, community health centre, home/web-based), intervention duration (less than 12 weeks, 12 weeks or longer), QOL scale (generic, disease-specific), and methodology quality (good, fair, poor). Sub-group analyses based on QOL scale and methodology quality were added post hoc. Meta-regression analyses were performed to determine the linear relationship between duration as a continuous covariate and the effect size. Meta analyses using different correlation coefficients (r = 0.8 and 0.4) were also conducted to compare the direction of effect and heterogeneity with the assumed coefficient (r = 0.6). All statistical analyses were performed using RStudio software, version 1.3.1073 [32]. The packages ‘meta’ [33] and ‘dmetar’ [34] were used for the analysis (R codes used in this study are available in the appendix as S1 Fig). All data are presented as standardized mean ± confidence interval (CI).

Results

Study selection

A total of 6122 studies were initially identified through database searching. After removing 3330 duplicates, 2792 studies were reviewed by title and abstract, of which, 431 progressed to full text review. Altogether, 386 studies were excluded after full text review. The list of excluded articles is presented in the appendix as S7 Table. Finally, 45 articles were included in the review, and 31 progressed to meta-analysis as illustrated in Fig 1.

Study characteristics

Twenty-four studies were conducted in lower middle-income countries [8,10,11,3555] and 21 were conducted in upper middle-income countries [9,5675]. The study duration ranged from 4 weeks [41] to 152 weeks [43], with more than half of studies exceeding a six-month study period. The total sample size was 8336, with individual sample sizes ranging from 30 [44] to 1570 [56]; 27 out of 45 studies had a sample size greater than 100. The mean age of the study participants ranged from 31 to 74 years. The percentage of female participants was higher than that of male participants in two-thirds of the studies. All studies included in the review reported a QOL measure, 27 reported HbA1c, 12 investigated changes in self-management behavior, and 3 examined changes in medication adherence. There was no dropout in the intervention group of 10 studies [11,35,41,45,46,48,49,64,75,76], while the highest intervention group dropout reported was 54.9% [67]. Similarly, there was no dropout in the control group of 11 studies [11,35,41,44,45,49,55,64,7476], while the highest control group dropout reported was 44.8% [57]. Detailed study characteristics are presented in Table 1.

Table 1. General characteristics of the studies included in the review sorted by author name alphabetically.

Author Year Objective of the study Study country Country classification Intervention type Intervention detail Control detail Study duration (weeks) Sample size (I/C) Study drop-out (I/C) % Age Mean (SD) Gender (I % Male/C % Male) Outcome measures of interest QOL tool
Abraham [47] 2020 to determine the effect of a cognitive educational intervention on HbA1c, QOL, selfcare and psychosocial measures India LMIC SME/CBT Educational intervention based on cognitive behavioral principles Usual routine medical care 22 40/40 25.0/37.5 I: 50.4 (9.3) C: 50.6 (8.3) 44/42 QOL, HbA1c, self-care DQOL
Akinci [67] 2018 to analyse the effects of supervised aerobic and resistance exercise and web-based exercise in people with T2DM Turkey UMIC Structured exercise 1. Supervised aerobic and resistance exercise 2. Web-based exercise performed with the help of exercise videos on aerobic and resistance exercises Brochure on importance and benefits of physical activity for people with diabetes 8 22/22/22 9.0/54.5/9.0 I1: 53.6 (6.0) I2: 50.2 (6.5) C: 53.6 (6.7) 18/33/38 QOL, HbA1c, physical activity, FBG, BMI EQ-5D-5L
Anderson [51] 2009 to determine the effectiveness of an empowerment-based self-management consultant in improving the glycemic and QOL outcomes in people with T2DM India LMIC SME Nurse and dietitian-led diabetes self-management consultation based on empowerment approach Mailed results of their metabolic assessments only 104 156/154 21.8/17.5 I: 55.5 (11.3) C: 55.7 (11.5) 44/39 QOL, HbA1c PAID
Arora [44] 2009 to examine the effects of progressive resistance training compared with aerobic exercise on glycemic and well-being outcomes in people with T2DM India LMIC Structured exercise 1. Supervised progressive resistance training 2. Supervised aerobic exercise Usual care with no exercise training but continued with their medication and nutritional regimen as before 8 10/10/10 5.0/0 I1: 49.6 (5.2) I2: 52.2 (9.3) C: 58.4 (1.8) 40/60/60 Well-being, HbA1c, BMI WBQ
Arovah [55] 2018 to determine the impact of a pedometer-based walking program based on social cognitive theory in people with T2DM Indonesia LMIC Structured exercise Social cognitive theory based physical activity intervention added to the provision of pedometers, also known as Walking with diabetes (WW-DIAB) program Pedometer and log sheet for recording steps only, which was not the focus of the research 24 21/22 4.7/0 I: 65.1 (5.2) C: 65.9 (6.5) 68/36 QOL, HbA1c, physical activity EQ-5D
Azami [8] 2018 to determine the effectiveness of a nurse-led diabetes self-management education on HbA1C. Iran LMIC SME Self-efficacy and motivational interviewing-based SME and follow-up telephone calls Usual diabetes routine care 26 71/71 2.8/5.6 I: 55.1 (10.2) C: 53.5 (10.9) 32/37 HbA1c, weight, BMI, QOL WHOQOL-Bref
Browning [66] 2016 to determine the effect of a coach-led educational intervention, based on motivational interviewing, in the glycemic and psychosocial outcomes of people with T2DM China UMIC SME Telephone and face-to-face health coaching based on motivational interviewing Usual care from Community health stations as per the Chinese Guideline for Diabetes Prevention and Management 104 385/345 15.5/12.4 I: 63.7 (7.6) C: 64.0 (9.0) 49/46 QOL, BMI, HbA1c, self-care activities WHOQOL-Bref
Butt [60] 2015 to analyze the impact of a pharmacist-led diabetes education program on HbA1c, medication compliance and QOL Malaysia UMIC SME Diabetes management education programme, called Patient Education by Pharmacist Programme Usual care at a medical centre which consisted of patient-physician meeting 26 37/36 10.8/8.3 I: 57.4 (7.2) C: 57.1 (10.8) 39/42 HbA1c, BMI, QOL EQ-5D-3L
Cani [70] 2015 to analyse the impact of a pharmacist-led program in diabetes self-mangement among people with T2DM Brazil UMIC SME Individualized pharmacotherapeutic care plan incorporating diabetes education Usual standard care 26 37/41 8.1/12.1 I: 61.91 (9.6) C: 61.58 (8.1) 38/39 QOL, HbA1c, medication adherence DQOL
Castillo-Hernandez [61] 2020 to explore if peer support in addition to a diabetes management education improves HbA1c and QOL outcomes Mexico UMIC SME Peer support SME for T2DM patients SME 35 29/29 3.4/10.3 I: 59.0 (9.4) C: 56.0 (10.3) 7/0 HbA1c, QOL, BMI, QOL, self-care behaviors Diabetes-39
Chaveepojnkamjorn [65] 2009 to assess the effect of a self-help group program on the QOL of people with T2DM Thailand UMIC SME Group education session and active learning for diabetes management Usual care at a health centre 30 80/84 8.7/13.1 I: 48.9 (6.9) C: 49.1 (7.3) 22/23 QOL WHOQOL-Bref
Cheng [62] 2019 to analyse the effects of a patient-centered empowerment based education approach on psychological outcomes in people with T2DM China UMIC SME Empowerment-based education intervention Attentional control, routine care with two general health education classes and social calls post-discharge 78 121/121 15.7/18.1 I: 56.1 (10.7) C: 53.9 (13.0) 77/71 QOL ADDQOL
Dede [75] 2015 to study the impact of a moderate intensity exercise training on the QOL of people with T2DM Turkey UMIC Structured exercise Supervised moderate intensity aerobic exercise training Normal daily activities without additional guided physical activities 12 30/30 0/0 I: 52.5 (7.5) C: 55.5 (8.4) 50/47 QOL, BMI SF-36
Ebrahimi [10] 2018 to determine the impact of family-based education on diabetes management in QOL outcomes of people with T2DM Iran LMIC SME Diabetes management education to T2DM patients and their families Usual standard care 12 40/40 5.0/5.0 I: 58.6 (7.7) C: 53.5 (9.2) 34/24 QOL DCQOL
Jaipakdee [68] 2015 to determine the effect of a self-management support program aided with computer-assisted instruction in people with T2DM Thailand UMIC SME Nurse-led diabetes support program equipped with a computer-aided instruction, designed in the RE-AIM framework Usual routine medical care 26 203/200 4.4/8.0 I: 61.1 (9.6) C: 61.5 (9.7) 24/23 QOL, HbA1c, health behavior score DQOL
Jamshidpour [46] 2020 to assess the impact of combined moderate intensity aerobic and resistance training in people with T2DM undergoing hemodialysis Iran LMIC Structured exercise Combined aerobic and resistance exercise performed at moderate intensity (11-15/20 on the Borg scale) during hemodialysis treatment Usual unmonitored and unrecorded physical activity 8 15/15 0/13.3 I: 64.9 (7.8) C: 58.5 (11.9) 80/61 QOL SF-36
Kong [72] 2019 to assess the effect of a chronic-care model-based intervetion on T2DM management China UMIC SME Comprehensive chronic care model to improve lifestyle behaviors Conventional care at the community health service centre 39 150/150 10.6/17.3 I: 69.1 (10.5) C: 71.5 (8.8) 42/44 QOL, BMI SF-36
Lyu [57] 2021 to develop and examine the effects of a web-based transitional care program on glycemic control and quality of life in Chinese population with T2DM China UMIC SME Web-based courses on knowledge of diabetes and self-management Usual care; routine discharge education and a diabetes knowledge manual consisting of general information on diabetes before discharge 13 54/52 6.9/10.3 I: 60.0 (10.0) C: 61.7 (10.5) 52/44 HbA1c, QOL, treatment adherence SF-36
Maharaj [37] 2015 to analyze the effects of rebound exercise and treadmill walking on the QOL of people with T2DM Nigeria LMIC Structured exercise 1. Supervised, structured moderate intensity rebound exercise 2. Treadmill walking for patients with T2DM Routine medication and counselling; health magazines to read 12 50/50/50 24.0/12.0 I 1: 38.7 (5.6) I 2: 40.8 (5.5) C: 40.0 (6.1) 59/51/52 QOL SF-36
Mash [56] 2014 to assess the effectiveness of group education in T2DM management in under-resourced settings in South Africa South Africa UMIC SME Group education based on diabetes management Usual education at the health centre that consisted of ad hoc educational talks 52 710/860 44.9/44.8 I: 55.8 (11.5) C: 56.4 (11.6) 28/24 HbA1c, weight, QOL, self-care activities SF-20
Mohammadi [36] 2018 to assess the impact of self-efficacy education based on Health Belief Model (HBM) in type 2 diabetes patients Iran LMIC SME Self-efficacy based diabetes education sessions Only conventional dietary counselling 36 120/120 8.3/8.3 I: 51.2 (6.2) C: 51.4 (6.0) - HbA1c, FBG, weight, BMI, QOL DQOL
Nazir [54] 2020 to examine the effectiveness of an educational intervention in a pharmacist led, medication management program targetted for people with T2DM Pakistan LMIC SME, medication adherence Pharmaceutical care/patient education through the medication therapy management program Usual routine medical care at a hospital 13 196/196 17.8/16.3 - 58/56 QOL, HbA1c EQ-5D
Nouripour [52] 2021 to examine the effect of high- protein versus high- carbohydrate evening diet on the quality of life of people with T2DM Iran LMIC Structured dietary high-carbohydrate versus high-protein intake during evening meal Standard evening meal 10 31/29/36 12.9/27.5/8.3 I1: 54.0 (6.3) I2: 51.7 (8.2) C: 56.1 (7.2) 52/48/44 QOL SF-36
Peimani [49] 2018 to assess the effectiveness of a peer support education program targetted at improving self-care behaviors and QOL in people with T2DM Iran LMIC SME Peer support group meetings focused on experience sharing and problem solving in diabetes self-care and management Usual clinic education 26 100/100 0/0 I: 59.0 (11.3) C: 58.8 (11.7) 53/51 QOL, HbA1c, BMI, self-management SWED-QUAL
Rasoul [11] 2019 to assess the effect of self-management education imparted through weblogs on the QOL of people with T2DM Iran LMIC SME Self-management education through weblog Routine care at a diabetes centre 22 49/49 0/0 I: 31.4 (5.3) C: 32.9 (4.4) 53 QOL, BMI DQOL
Rias [48] 2020 to compare the effects of regular walking, consumption of alkaline electrolysed water, and their combined effect in people with T2DM Indonesia LMIC Structured exercise 1. Regular walking for at least 150 min/week 2. Drink 2 L/day of alkaline electrolysed water 3. Drink 2 L/day of alkaline electrolysed water and regular walk for at least 150 min/week Continued with their habitual diet and physical activity 8 20/20/20/21 0/0/0/4.7 I1: 54.7 (4.9) I2: 57.5 (5.5) I3: 56.2 (4.9) C: 55.7 (4.9) 35/45/35/38 QOL, FBG SF-36
Rondhianto [38] 2018 to investigate the effect of diabetes education based on health belief model on psychosocial and glycemic outcomes Indonesia LMIC SME Education program based on the health belief model Usual care 18 60/60 Unclear I: 57.5 (6.8) C: 57.7 (5.7) 30/43 HbA1c, QOL, self-care behavior Diabetes QOL scale
Safavi [73] 2011 to assess the effectiveness of an education program in improving the QOL and self-esteem in people with T2DM Iran UMIC SME Diabetes management education focussed on quality of life improvement Waitlist control; handouts and the same QOL education programs after post-intervention data collection 60 61/62 Unclear I>C (p = 0.016) 49/48 QOL, BMI Farrell and Grant quality of life questionnaire
Saghaee [41] 2020 to assess the impact of a culture and theory based self-management education on self care activity and QOL of people with T2DM Iran LMIC SME Culture-oriented, theory and evidence-based, education workshops based on management of diabetes and reducing risk of complications Non-interactive routine diabetes education 4 17/17 0/0 I: 66.3 (6.4) C: 69.1 (7.8) 53/65 QOL, self-care behavior Diabetes QOL Brief Clinical Inventory (DQOL-BCI)
Sekhar [43] 2019 to study the effect of patient education on patient with diabetic foot ulcer India LMIC SME Patient counselling and education on foot care measures using patient information leaflets Usual care 152 210* 35.7# I: 58.6 (7.9) C: 60.3 (8.4) 79/74 QOL SF-36
Shahsavari [45] 2021 to evaluate the effect of peer support on the quality of life of people with T2DM Iran LMIC SME Peer support intervention on diabetes self-care and telephone follow up for T2DM patients Usual routine medical care 13 40/40 0/0 I: 53.6 (14.3) C: 54.5 (12.9) 43/40 QOL DQOL-BCI
Shenoy [35] 2009 to analyze the effects of aerobic walking on HbA1c, blood glucose and well-being in patients with type 2 diabetes India LMIC Structured exercise Supervised walking program using heart rate monitor and pedometer No exercise training; continued with their medication as before
8 20/20 0/0 I: 53.1 (4.4) C: 51.0 (5.4) 75/70 HbA1c, BMI, General well-being WBQ
Shi [71] 2018 to determine the effect of an integrative health education based on Chinese medicine and Western medicine therapy in the glycemic and QOL outcomes in people with T2DM China UMIC SME Integrative health education including Western medicine education about diabetes health and therapeutic Chinese method such as Chinese dietary therapy and food choices Usual education with handbooks of diabetes 52 129/127 6.9/5.5 I: 52.95 (14.0) C: 55.3 (13.4) 46/46 QOL, BMI SF-36
Singh [40] 2020 to investigate the effect of yoga and exercise on glycemic control, QOL outcome, and exercise self-efficacy India LMIC Structured exercise Supervised yoga sessions for 2 weeks, followed by home practice for 3 months Usual care and general information on diabetes 14 112/115 10.3/13.9 I: 50.3 (9.1) C: 49.4 (8.7) 41/49 QOL, HbA1c QOLID
Sreedevi [39] 2017 to assess the effects of yoga and peer support intervention on women with T2DM India LMIC Structured exercise and peer-led SME 1. Instructor driven yoga sessions 2. Peer support intervention by peer mentors identified from the community Usual standard of care 12 41/42/41 22.8/14.6 I 1: 52.0 (7.4) I 2: 51.9 (8.3) C: 51.9 (6.6) 0/0/0 QOL, HbA1c, FPG, medication adherence WHOQOL-Bref
Sunil [53] 2020 to assess the impact of a mobile application focusing on lifestyle change and medication management in the QOL of people with T2DM India LMIC SME Smartphone application named ’Diaguru’ for lifestyle modification and medication management Usual routine medical care 26 150/150 0/0 I: 55.7 (10.5) C: 73.6 (11.3) 60/60 QOL WHOQOL-Bref
Tapehsari [50] 2020 to study the effect of Physical Activity Package (PAP) conducted with the help of an exercise prescription on the quality of life of people with T2DM Iran LMIC Structured exercise with SME Physical activity package program run with the help of exercise prescriptions by physicians Usual general lifestyle education 12 50/50 6.0/4.0 I: 45.9 (6.9) C: 46.6 (5.3) 19/15 QOL, FBG WHOQOL-Bref
Torabizadeh [42] 2018 to determine the impact of problem-solving technique on glycemic outcome and QOL of cognitively impaired people with T2DM Iran LMIC SME/CBT Empowerment-based education intervention with problem-solving approach Usual routine classes in the clinic 19 50/50 2.0/6.0 I: 52.6 (7.0) C: 50.7 (7.5) 27/21 QOL, HbA1c, FBG, self-care behaviors QOLID
Umphonsathien [64] 2022 to analyse the impact of intermittent very-low calorie diet on glycemic, metabolic and QOL outcomes in peope with T2DM Thailand UMIC Structured dietary 1. Calorie restricted diet (600 kcal per day) for two days/week 2. Calorie restricted diet (600 kcal per day) for four days/week, and ad libitum food consumption on non-restricted days in both groups Usual standard diabetes care and normal diet of 1500 to 2000 Kcal/day 124 14/14/12 0/0 I 1: 49.5 (7.2) I 2: 47.6 (7.9) C: 52.0 (6.0) 14/50/17 QOL, HbA1c, FPG, BMI SF-36
Wattana [58] 2007 to assess the effects of a diabetes self-management education program on HbA1c, coronary heart disease risk and QOL among people with T2DM Thailand UMIC SME Education based on the theories of self-efficacy and self-management, followed by home visits Usual nursing care that consisted of physical examination and general health education based on the institutional guideline 26 79/78 5.0/7.6 I: 58.4 (10.1) C: 55.1 (10.2) 20/28 HbA1c, QOL SF-36
Wichit [9] 2017 to determine the effects of a family-oriented education program in people with T2DM Thailand UMIC SME Family-oriented self-management intervention based on the self-efficacy theory Usual care from clinical staff
13 70/70 4.3/4.3 I: 61.3 (11.6) C: 55.5 (10.5) 24/30 HbA1c, QOL, diabetes self-management SF-12
Wongrochananan [69] 2015 to study the effect of an interactive multi-modality intervention comprising of sms, email and website in enhancing self-management behavior in people with T2DM Thailand UMIC SME Use of interactive multi-modality (IMM) intervention consisting of website, email, and SMS to help improve self-management behaviors Usual general education/advice through email 26 78/48 29.4/37.5 I: 53.6 (8.6) C: 51.3 (7.9) 56/50 QOL, self-care behavior DQOL
Yang [74] 2022 to examine the effect of a telemedicine education approach in improving metabolic and QOL outcomes in people with T2DM China UMIC SME A WeChat public telemedicine management platform called “The home of Xinqiao nutrition” to monitor self-management behaviors and monthly education via telephone Usual standard of care at a hospital 65 50/50 6.0/0 I: 65.1 (6.1) C: 67.3 (5.3) 38/42 QOL, HbA1c SF-36
Yucel [63] 2015 to determine the effects of pilates-based mat exercise on glycemic and psychological outcomes in people with T2DM Turkey UMIC Structured exercise Pilates based mat exercise involving warm-up; stretching; basic aerobic Pilates training for arms, legs, and body; and cool-down. Usual routine medical care 12 28/28 14.3/25.0 I: 58.5 (7.0) C: 53.3 (9.0) 0/0 QOL, HbA1c, FBG SF-36
Zuo [59] 2020 to assess the effect of CBT on sleep disturbances and QOL in people with T2DM China UMIC SME/CBT Cognitive behavioral therapy with aerobic exercise Usual care, i.e., face to face visit with the medical staff in a healthcare service 39 96/95 2.0/2.1 I: 63.9 (10.2) C: 61.7 (10.4) 34/31 QOL, HbA1c Diabetes specific QOL scale

*: Total sample size

#: Overall study drop-out rate.

UMIC: Upper-middle income country, LMIC: Lower-middle income country, SME: Self-management education, I/C: Intervention/Control, QOL: Quality of life, HbA1c: glycated haemoglobin, BMI: Body mass index, FBG: Fasting blood glucose, FPG: Fasting plasma glucose, SF: Short form, WBQ: Well-being questionnaire, WHOQOL-Bref: Abbreviated World Health Organization Quality of Life questionnaire, EQ5D: European quality of life-5D, QOLID: Quality of life instrument for Indian diabetes patients, DQOL: Diabetes Quality of Life, DCQOL: Diabetic Clients Quality of life, DQOL-BCI: Diabetes QOL Brief Clinical Inventory, SWED-QUAL: Swedish Health-Related Quality of Life Survey, ADDQOL: Audit of diabetes dependant Quality of Life, PAID: Problem Areas in Diabetes.

Health behavior intervention characteristics

Thirty-one out of 45 studies involved DSME interventions, the education content of which focused on physical activity and/or diet (n = 23), medication advice (n = 20), glucose monitoring (n = 19), foot care (n = 17), problem solving and stress reduction (n = 13). Of the remaining 14 studies, 10 were structured exercise programs [35,37,40,44,46,48,55,63,67,75], two were structured dietary programs [52,64], and two were the combination of structured exercise and DSME programs [39,50].

The majority of the interventions (28) were delivered by health care professionals (HCP) [8,9,41,43,50,54,5760,62,65,68,7073], followed by allied health professionals (AHP)/exercise trainers [37,44,46,47,52,55,63,67,75] and peer-supporter or lay people trained to deliver the intervention [45,48,49,56,61]. There was no mention of who delivered the interventions in eight studies [11,35,36,38,53,64,69,74].

The intervention settings varied from community health centres [38,39,56,59,61,65,66,68,72,74], hospital/diabetes clinics [811,36,37,4043,4547,49,50,5254,57,58,60,6264,67,70,71,73] to home/web-based [48,55]. The intervention duration varied from four weeks [41] to 104 weeks [51], with majority of the studies delivering the intervention for three months or more. The median duration of the interventions was 18 weeks.

Fifteen studies [9,37,43,46,48,52,5658,63,64,71,74,75,77] reported using various versions of SF questionnaires (SF-12, SF-20, SF-36) as a QOL measurement tool. The remaining studies used other generic (e.g., the World Health Organisation QOL questionnaire) and diabetes-specific (e.g., Diabetes-39) questionnaires, as summarized in S2 Table. Similarly, mean values for the overall QOL or domain specific QOL were extracted along with the values of secondary outcome measures (S3 Table).

Quality assessment

An overview of the quality assessment of the studies is presented in the appendix as S4 Table. The overall quality of the studies ranged from “fair” to “good” after obtaining a summary score of at least six in the quality assessment. No study was rated as poor quality as none obtained a summary score of five or less. Allocation of study participants to intervention and control groups wasn’t concealed in three studies and not clearly indicated in 23 studies. Only two studies clearly specified blinding of participants, five stated blinding of those delivering the intervention, and 13 specified blinding of outcome assessors. Use of appropriate trial design and statistical analysis methodology was strong in all studies. Thirty-eight studies provided information on participants’ attrition with reasons for dropouts and withdrawals. In 23 studies, the data were analysed following the intention-to-treat principle.

The quality of evidence across studies included in the meta-analyses, assessed using the GRADE approach, is presented in the appendix as S5 Table, and the description is provided below, under each meta-analysis heading–“Meta-analysis of Mean QOL scores”, “Meta-analysis of Physical Component Summary Scores”, and “Meta-analysis of Mental Component Summary Scores”.

Effect of behavior interventions on quality of life

Meta-analysis of Mean QOL scores

Twenty-five studies reported overall QOL scores (participants n = 3,867). The health behavior interventions achieved a significant improvement in the QOL score compared to the control, with a large effect size (SMD: 1.62, 95% CI: 0.65 to 2.60 I2: 0.96, p-value: 0.001) (Fig 2). Meta-analysis using different correlation coefficient (r = 0.4 and 0.8) did not change the direction of the effect or the heterogeneity (S6 Table).

Fig 2. Forest plot comparing mean QOL scores of intervention and control group.

Fig 2

The overall QOL score was not significantly different based on the subgroup analysis of intervention types (Q = 0.17, p-value = 0.63) or setting (Q = 0.49, p-value = 0.78) (S6 Table). However, interventions based in hospital/clinic (n = 21) and community health care (n = 4) significantly improved QOL compared to those based in home/web-based (although low number of studies included in this group, n = 2). Meta-regression analysis did not suggest a linear relationship between duration of intervention and mean QOL scores (Q = 1.13, p-value = 0.28). However, subgroup analysis suggested that interventions that were 12 weeks or longer significantly improved the overall QOL compared to interventions less than 12 weeks long (without a significant sub-group difference Q = 0.84, p-value = 0.36). Subgroup analyses based on types of QOL scales did not suggest significant differences in QOL between studies that used generic scale compared to those that used diabetes-specific scale (Q = 0.80, p-value = 0.37). Subgroup analysis based on methodology quality of included studies resulted in a significant improvement in mean QOL in interventions that deemed to have a ‘good’ quality of methodology (n = 21). Interventions with ‘fair’ method quality (n = 6) did not result in a significant improvement in mean QOL (n = 6). However, the test for subgroup analysis was not significant (Q = 0.66, p-value = 0.41) (S6 Table).

In the GRADE certainty of evidence assessment, the studies were downgraded one level each due to high heterogeneity (I2: 94%) and the presence of publication bias as seen in the funnel plot (S2 Fig). However, due to large effect size (SMD: 1.62), the studies were upgraded by one level. Overall, the GRADE certainty of evidence was classified as moderate quality (S5 Table).

Funnel plot (S2 Fig) showed degree of asymmetry, aligned with the high heterogeneity observed.

Meta-analysis of Physical Component Summary scores

Seven studies reported PCS scores (participants n = 834). The effect of health behavior interventions on PCS score did not reach a statistical significance level compared to the control group (SMD: 0.76, 95% CI: -0.03 to 1.56 I2: 0.94, p-value: 0.060) (Fig 3).

Fig 3. Forest plot comparing mean PCS score of intervention and control group.

Fig 3

Overall PCS score was not significantly different based on the subgroup analysis of intervention types (Q = 0.05, p-value = 0.82). Subgroup analysis based on settings resulted in a significant difference (Q = 37.52, p-value<0.001), with the subgroup of community health centre resulting in a large significant effect size (SMD: 3.22, 95% CI: 2.26, 4.17), but this was based on only one study. Overall PCS score was not significantly different based on the subgroup analysis of intervention duration (Q = 0.29, p-value = 0.58) (S6 Table). Subgroup analysis of overall PCS scores based on methodology quality of included studies was not different between studies that deemed to have a ‘good’ methodology quality (n = 7) compared to the one study that had a fair methodology quality (S6 Table). Meta-regression analysis also did not suggest a linear relationship between duration of the behavior change intervention and changes in the PCS scores (Q = 0.36, p-value = 0.546).

Due to high heterogeneity (I2: 94%) and imprecise results (wide CI), the GRADE certainty of evidence was classified as low quality (S5 Table).

Funnel plot (S3 Fig) also showed some degree of asymmetry, aligned with the high heterogeneity observed.

Meta-analysis of Mental Component Summary scores

Seven studies reported MCS scores (participants n = 834). The effect of health behavior interventions on the MCS score did not reach statistical significance compared to the control group (SMD: 0.43, 95% CI: -0.30 to 1.16 I2: 0.94, p-value: 0.249) (Fig 4).

Fig 4. Forest plot comparing mean MCS score of intervention and control group.

Fig 4

Overall, the MCS score was not significantly different based on the subgroup analysis of intervention types (Q = 0.40, p-value = 0.48). Subgroup analysis based on settings resulted in a significant difference (Q = 30.60, p-value<0.001), with subgroup of community health centre resulting in a large significant effect size (SMD: 1.23, 95% CI: 0.56, 1.90), but this was based on only one study. Overall, the MCS score was not significantly different based on the subgroup analysis of intervention duration (Q = 0.05, p-value = 0.814) (S6 Table). Subgroup analysis of overall MCS scores based on methodology quality of included studies was not different between studies that deemed to have a ‘good’ methodology quality (n = 7) compared to the one study that had a fair methodology quality (S6 Table). Meta-regression analysis also did not suggest a linear relationship between duration of the behavior change intervention and changes in the MCS scores (Q = 0.035, p-value = 0.350).

Due to high heterogeneity (I2: 94%) and imprecise results (wide CI), the GRADE certainty of evidence was classified as low quality (S5 Table).

Funnel plot (S4 Fig) of studies reporting MCS scores showed some degree of asymmetry, aligned with the high heterogeneity observed.

Overall, fourteen studies were excluded from the meta-analysis because they reported domain specific QOL scores, but not the total mean QOL scores or composite (PCS or MCS) scores.

Effect of health behavior interventions on secondary outcomes

Since the primary aim of this study was to systematically review and meta-analyse QOL outcomes, secondary outcomes were not meta-analysed. However, we did find that 25 out of 45 studies included in the review reported reduction in HbA1c in the intervention group. The reduction in 13 (52%) of those studies was statistically significant. Seventeen studies reported reduction in BMI in the intervention group, six of which were statistically significant. Similarly, seven studies reported changes in FBG, with three demonstrating a significant reduction in the intervention group. Four studies reported non-significant improvement in dietary behavior and six studies reported improvement in physical activity behavior, where one showed a statistically significant improvement. Two studies showed significant improvement in medication adherence in the intervention group. Three studies showed improvement in foot care in the intervention group, although not statistically significant.

Discussion

This systematic review analysed and synthesized the evidence from 45 RCTs to assess the impact of health behavior interventions to manage T2DM on the QOL of people in LMICs. Overall, the review demonstrated great heterogeneity in terms of type of intervention, description and duration of intervention, and the outcome measures. Nevertheless, the review suggested that health behavior interventions for improving T2DM management can improve QOL, along with glycemic outcome and self-care behaviors.

Our meta-analysis found a significant improvement in the overall QOL scores with a large effect size of 1.62 (95% CI: 0.65 to 2.60). This is comparable to previous meta-analyses of DSME interventions that showed statistically significant improvement in the QOL, albeit with small effect sizes of 0.26 [78] and 0.28 [79] respectively. Improved health behaviors can prevent diabetes comorbidity and complications as patients need to take less medications and worry less about the care associated with the complications [80]. Furthermore, positive health behaviors such as regular physical activity have shown to improve insulin sensitivity [81], which is significantly associated with QOL [82]. Another explanation to improved QOL could be improved self-management behaviors attributed to self-efficacy, as studies have shown that positive behavior change among people with diabetes is mediated by self-efficacy, which is found to have a strong positive correlation with QOL [83,84].

Our meta-analysis including seven studies didn’t find any significant changes in the PCS (SMD: 0.76, 95% CI: -0.03 to 1.56) or MCS (SMD: 0.43, 95% CI: -0.30 to 1.16) measures of QOL. The limited number of studies presenting the PCS and MCS scores, small sample size and short intervention duration of the trials might explain these findings. The eight subscales of the SF questionnaire—physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health contribute in different proportions in the calculation of the PCS and MCS scores, which involves a special scoring algorithm. However, there have been concerns regarding the validity of the scoring method used to generate PCS and MCS scores [85,86]. Furthermore, the developers of SF questionnaire do not approve of combining these summary measures to generate a total QOL score [87], hence, many researchers tend to present only the eight-subscale data and not calculate the physical and mental summary measures [37,56,66,74].

Sub-group analysis based on intervention setting showed a significant difference in the PCS (d = 3.22, Q = 37.52, p-value<0.001) and MCS (d = 1.22, Q = 30.60, p-value<0.001) scores for the subgroup of studies conducted in community health centres. This could imply that an intervention delivered at community health centres is more effective in improving the QOL in the physical and mental dimensions of health. However, these analyses had only one study each, hence, it warrants caution in interpretation. The finding is congruent to a review which suggested that health education intervention delivered at a community health setting is more effective in improving QOL and self-management behaviors compared to patient-focused hospital setting [88].

In relation to secondary outcomes, our findings indicated that health behavior interventions are effective in improving T2DM patients’ glycemic, anthropometric and self-care measures. Statistically significant reductions were seen in metabolic outcomes (HbA1c, FBG), also supported by multiple reviews [6,15,89]. Similarly, dietary behavior and physical activity were found to have improved post-interventions, but not significantly. Studies have questioned whether diet change plans are sustainable and implementable in the long run, which may explain why no significant improvement was seen in dietary behavior [90,91]. In addition, the low number of studies that reported dietary and physical activity outcomes in this review might explain the lack of statistical significance. Statistically significant improvement in medication adherence, as seen in this review, could be attributed to the combined educational/behavioral intervention strategy designed and implemented to improve patient knowledge and awareness on medication adherence for better diabetes outcomes [92].

Strengths and limitations

Our study has several strengths. It is the first systematic review and meta-analysis to study and synthesize available evidence on the effect of health behavior interventions on QOL in people with T2DM in LMICs. A relatively large sample size (n = 8336) in this review ensures greater reliability that behavioral interventions are indeed effective in improving the QOL in people with T2DM. This also addresses the limitation of previous meta-analyses only having a secondary focus on QOL outcomes, whose interpretation of change in QOL was limited due to a much smaller sample size (n = 2645) [78]. Another strength is that all the studies included in this review and meta-analysis were RCTs, as this strengthens the internal validity and minimises the chances of confounders [93]. Similarly, not using LMIC search terms in our search strategy, but rather searching for the studies conducted worldwide and later differentiating the retrieved studies based on income regions may have affected the number of studies we retrieved. We believe this search strategy generated more results, hence allowing us to more thoroughly examine studies conducted worldwide and extract the ones that met the objective of this study in terms of setting.

This study also has limitations. Firstly, as expected, the heterogeneity of the studies was high as the scales used to measure QOL in the RCTs varied widely. The complexity of QOL constructs and lack of a standard definition has resulted in a wide variety of tools being used in the QOL measurement. Secondly, we excluded the studies that only presented the domain-specific scores instead of PCS, MCS or overall scores in the meta-analysis. Thirdly, the findings of this meta-analysis only related to short-term QOL of participants (i.e., immediate post-intervention effects) and any lasting/sustained effect was not examined in this review as there was no sufficient data to examine longer term effects on QOL. Similarly, the potential of reporting bias in the included RCTs may have influenced the findings of our review. Only including studies published in English language in the review is another limitation. Lastly, the limited number of interventions measuring QOL outcomes hinders the possibility of comparing our findings with prior studies. Therefore, more RCTs should include QOL measures to enable future researchers to pool studies that have used similar QOL measurement approaches in their meta-analyses. Furthermore, large and well-powered RCTs of high methodological quality are necessary to establish the effect of health behavior interventions on QOL.

Conclusion

In conclusion, this systematic review and meta-analysis identified health behavior interventions targeted at improving T2DM management as effective strategies in improving the QOL of people with T2DM. The study demonstrated a moderate certainty of evidence for the overall QOL findings, indicating that the immediate post-intervention improvement on the overall QOL of people with T2DM is likely to be close to the true effect of the interventions on QOL over the short term. However, the low quality of evidence of PCS and MCS findings limits the strength of our conclusion from the pooled evidence. Due to the variability of the scales used in QOL measurement, the interpretation of our findings warrants caution. Studies with specific standardized scales are recommended for more robust estimates. Further research is needed to examine the long-term effectiveness of health behavior interventions on QOL. Furthermore, this review highlights the need for more well-designed RCTs of high methodological quality focusing on QOL as a primary outcome measure. The evidence generated from this review may guide future research and clinical practice and may derive policy implications for the management of T2DM in LMICs.

Supporting information

S1 Checklist. PRISMA checklist.

(DOC)

S1 Fig. R codes used in the meta-analysis.

(DOCX)

S2 Fig. Funnel plot of Mean QOL.

(DOCX)

S3 Fig. Funnel plot of Mean Physical Component Summary.

(DOCX)

S4 Fig. Funnel plot of Mean Mental Component Summary.

(DOCX)

S1 Table. Detailed search strategy.

(DOCX)

S2 Table. Intervention characteristics of studies included in the review sorted alphabetically by author.

(DOCX)

S3 Table. Effect of health behavior intervention on the primary (quality of life) and secondary outcomes.

(DOCX)

S4 Table. Quality assessment of studies using Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Randomized Controlled Trials.

(DOCX)

S5 Table. GRADE certainty of evidence.

(DOCX)

S6 Table. Subgroup analyses.

(DOCX)

S7 Table. List of studies excluded during full-text screening.

(DOCX)

Acknowledgments

The authors would like to acknowledge the research librarian of Central Queensland University for providing support in building search strategy.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.World Health Organization. World Health Statistics 2016: Monitoring Health for the Sdgs, Sustainable Development Goals. 2016. [Available from: https://apps.who.int/iris/handle/10665/206498. [Google Scholar]
  • 2.International Diabetes Federation. Idf Diabetes Atlas, 10th Edn. Brussels, Belgium 2021. [Available from: https://www.diabetesatlas.org/. [Google Scholar]
  • 3.Mishra SR, Sharma A, Bhandari PM, Bhochhibhoya S, Thapa K. Depression and Health-Related Quality of Life among Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Nepal. PLOS ONE. 2015;10(11):e0141385. doi: 10.1371/journal.pone.0141385 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tran BX, Nguyen LH, Pham NM, Vu HTT, Nguyen HT, Phan DH, et al. Global Mapping of Interventions to Improve Quality of Life of People with Diabetes in 1990–2018. International Journal of Environmental Research and Public Health. 2020;17(5):1597. doi: 10.3390/ijerph17051597 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zhang X, Norris SL, Chowdhury FM, Gregg EW, Zhang P. The Effects of Interventions on Health-Related Quality of Life among Persons with Diabetes: A Systematic Review. Medical Care. 2007;45(9):820–34. doi: 10.1097/MLR.0b013e3180618b55 [DOI] [PubMed] [Google Scholar]
  • 6.O’Donoghue G O l C, Corridan I, Daly J, Finn R, Melvin K, et al. Lifestyle Interventions to Improve Glycemic Control in Adults with Type 2 Diabetes Living in Low-and-Middle Income Countries: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Rcts). Int J Environ Res Public Health. 2021;18(12). doi: 10.3390/ijerph18126273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Daundasekara SS, Arlinghaus KR, Johnston CA. Quality of Life: The Primary Goal of Lifestyle Intervention. Am J Lifestyle Med. 2020;14(3):267–70. doi: 10.1177/1559827620907309 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Azami G, Soh KL, Sazlina SG, Salmiah MS, Aazami S, Mozafari M, et al. Effect of a Nurse-Led Diabetes Self-Management Education Program on Glycosylated Hemoglobin among Adults with Type 2 Diabetes. J Diabetes Re s. 2018;2018:4930157. doi: 10.1155/2018/4930157 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wichit N, Mnatzaganian G, Courtney M, Schulz P, Johnson M. Randomized Controlled Trial of a Family-Oriented Self-Management Program to Improve Self-Efficacy, Glycemic Control and Quality of Life among Thai Individuals with Type 2 Diabetes. Diabetes research and clinical practice. 2017;123:37–48. doi: 10.1016/j.diabres.2016.11.013 [DOI] [PubMed] [Google Scholar]
  • 10.Ebrahimi H, Ashrafi Z, Rudsari DM, Parsayekta Z, Haghani H. Effect of Family-Based Education on the Quality of Life of Persons with Type 2 Diabetes: A Randomized Clinical Trial. Journal of nursing research. 2018;26(2):97–103. doi: 10.1097/jnr.0000000000000212 [DOI] [PubMed] [Google Scholar]
  • 11.Rasoul AM, Jalali R, Abdi A, Salari N, Rahimi M, Mohammadi M. The Effect of Self-Management Education through Weblogs on the Quality of Life of Diabetic Patients. BMC Med Inform Decis Mak. 2019;19(1):205. doi: 10.1186/s12911-019-0941-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kumah E, Otchere G, Ankomah SE, Fusheini A, Kokuro C, Aduo-Adjei K, et al. Diabetes Self-Management Education Interventions in the Who African Region: A Scoping Review. PLOS ONE. 2021;16(8):e0256123. doi: 10.1371/journal.pone.0256123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Flood D, Hane J, Dunn M, Brown SJ, Wagenaar BH, Rogers EA, et al. Health System Interventions for Adults with Type 2 Diabetes in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. PLoS Medicine. 2020;17(11). doi: 10.1371/journal.pmed.1003434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Speight J, Holmes-Truscott E, Hendrieckx C, Skovlund S, Cooke D. Assessing the Impact of Diabetes on Quality of Life: What Have the Past 25 Years Taught Us? Diabet Med. 2020;37(3):483–92. doi: 10.1111/dme.14196 [DOI] [PubMed] [Google Scholar]
  • 15.Mikhael EM, Hassali MA, Hussain SA. Effectiveness of Diabetes Self-Management Educational Programs for Type 2 Diabetes Mellitus Patients in Middle East Countries: A Systematic Review. Diabetes Metab Syndr Obes. 2020;13:117–38. doi: 10.2147/DMSO.S232958 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mohamed A, Staite E, Ismail K, Winkley K. A Systematic Review of Diabetes Self-Management Education Interventions for People with Type 2 Diabetes Mellitus in the Asian Western Pacific (Awp) Region. Nurs Open. 2019;6(4):1424–37. doi: 10.1002/nop2.340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ajala O, English P, Pinkney J. Systematic Review and Meta-Analysis of Different Dietary Approaches to the Management of Type 2 Diabetes. Am J Clin Nutr. 2013;97(3):505–16. doi: 10.3945/ajcn.112.042457 [DOI] [PubMed] [Google Scholar]
  • 18.Zhao X, He Q, Zeng Y, Cheng L. Effectiveness of Combined Exercise in People with Type 2 Diabetes and Concurrent Overweight/Obesity: A Systematic Review and Meta-Analysis. BMJ Open. 2021;11. doi: 10.1136/bmjopen-2020-046252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Jayedi A, Emadi A, Shab-Bidar S. Dose-Dependent Effect of Supervised Aerobic Exercise on Hba(1c) in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Sports Med. 2022;52(8):1919–38. doi: 10.1007/s40279-022-01673-4 [DOI] [PubMed] [Google Scholar]
  • 20.van der Heijden MM, van Dooren FE, Pop VJ, Pouwer F. Effects of Exercise Training on Quality of Life, Symptoms of Depression, Symptoms of Anxiety and Emotional Well-Being in Type 2 Diabetes Mellitus: A Systematic Review. Diabetologia. 2013;56(6):1210–25. doi: 10.1007/s00125-013-2871-7 [DOI] [PubMed] [Google Scholar]
  • 21.Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The Prisma Statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tufanaru C MZ, Aromataris E, Campbell J, Hopp L. Chapter 3: Systematic Reviews of Effectiveness. In: Aromataris E, Munn Z (Editors). Jbi Manual for Evidence Synthesis. Jbi; 2020. [Available from: https://synthesismanual.jbi.global. 10.46658/JBIMES-20-04. [DOI] [Google Scholar]
  • 23.The World Bank. World Bank Country and Lending Groups 2022. [Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. [Google Scholar]
  • 24.Veritas Health Innovation. Covidence Systematic Review Software 2021. [Available from: http://www.covidence.org/. [Google Scholar]
  • 25.Waffenschmidt S, Knelangen M, Sieben W, Bühn S, Pieper D. Single Screening Versus Conventional Double Screening for Study Selection in Systematic Reviews: A Methodological Systematic Review. BMC Medical Research Methodology. 2019;19(1):132. doi: 10.1186/s12874-019-0782-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Joanna Briggs Institute. Critical Appraisal Tools 2017. [Available from: https://jbi.global/critical-appraisal-tools. [Google Scholar]
  • 27.John JR, Jani H, Peters K, Agho K, Tannous WK. The Effectiveness of Patient-Centred Medical Home-Based Models of Care Versus Standard Primary Care in Chronic Disease Management: A Systematic Review and Meta-Analysis of Randomised and Non-Randomised Controlled Trials. Int J Environ Res Public Health. 2020;17(18). doi: 10.3390/ijerph17186886 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. Grade: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations. Bmj. 2008;336(7650):924–6. doi: 10.1136/bmj.39489.470347.AD [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Peiris CL, van Namen M, O’Donoghue G. Education-Based, Lifestyle Intervention Programs with Unsupervised Exercise Improve Outcomes in Adults with Metabolic Syndrome. A Systematic Review and Meta-Analysis. Rev Endocr Metab Disord. 2021;22(4):877–90. doi: 10.1007/s11154-021-09644-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Higgins JPT, Thomas J., Chandler J., Cumpston M., Li T., Page M.J., et al. Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (Updated July 2019). Cochrane; 2019. [Available from: www.training.cochrane.org/handbook. [Google Scholar]
  • 31.Hedges LV. Distribution Theory for Glass’s Estimator of Effect Size and Related Estimators. Journal of Educational Statistics. 1981;6(2):107–28. [Google Scholar]
  • 32.RStudio Team. Rstudio: Integrated Development Environment for R. Rstudio, Pbc, Boston, Ma 2020 [Available from: http://www.rstudio.com/.
  • 33.Balduzzi S, Rucker G, Schwarzer G. How to Perform a Meta-Analysis with R: A Practical Tutorial. Evid Based Ment Health. 2019;22(4):153–60. doi: 10.1136/ebmental-2019-300117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Harrer M, Cuijpers P., Furukawa T. & Ebert D. Dmetar D,: Companion R Package for the Guide ’Doing Meta-Analysis in R’. R Package Version 0.0.9000. 2019. [Available from: http://dmetar.protectlab.org. [Google Scholar]
  • 35.Shenoy S, Guglani R, Sandhu JS. Effectiveness of an Aerobic Walking Program Using Heart Rate Monitor and Pedometer on the Parameters of Diabetes Control in Asian Indians with Type 2 Diabetes. Prim Care Diabetes. 2010;4(1):41–5. doi: 10.1016/j.pcd.2009.10.004 [DOI] [PubMed] [Google Scholar]
  • 36.Mohammadi S, Karim NA, Talib RA, Amani R. The Impact of Self-Efficacy Education Based on the Health Belief Model in Iranian Patients with Type 2 Diabetes: A Randomised Controlled Intervention Study. Asia Pac J Clin Nutr. 2018;27(3):546–55. doi: 10.6133/apjcn.072017.07 [DOI] [PubMed] [Google Scholar]
  • 37.Maharaj SS, Nuhu JM. The Effect of Rebound Exercise and Treadmill Walking on the Quality of Life for Patients with Non-Insulin-Dependent Type 2 Diabetes. International journal of diabetes in developing countries. 2015;35:S223–S9. [Google Scholar]
  • 38.Rondhianto Kusnanto, Melaniani S. The Effect of Diabetes Self-Management Education, Based on the Health Belief Model, on the Psychosocial Outcome of Type 2 Diabetic Patients in Indonesia. Indian Journal of Public Health Research and Development. 2018;9(11):1718–23. [Google Scholar]
  • 39.Sreedevi A, Unnikrishnan AG, Karimassery SR, Deepak KS. The Effect of Yoga and Peer Support Interventions on the Quality of Life of Women with Diabetes: Results of a Randomized Controlled Trial. Indian Journal of Endocrinology and Metabolism. 2017;21(4):524–30. doi: 10.4103/ijem.IJEM_28_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Singh VP, Khandelwal B. Effect of Yoga and Exercise on Glycemic Control and Psychosocial Parameters in Type 2 Diabetes Mellitus: A Randomized Controlled Study. International journal of yoga. 2020;13(2):144–51. doi: 10.4103/ijoy.IJOY_45_19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Saghaee A, Ghahari S, Nasli-Esfahani E, Sharifi F, Alizadeh-Khoei M, Rezaee M. Evaluation of the Effectiveness of Persian Diabetes Self-Management Education in Older Adults with Type 2 Diabetes at a Diabetes Outpatient Clinic in Tehran: A Pilot Randomized Control Trial. Journal of diabetes and metabolic disorders. 2020;19(2):1491–504. doi: 10.1007/s40200-020-00684-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Torabizadeh C, Jalali K, Moattari M, Moravej H. Effects of the Problem Solving Technique in Type 2 Diabetic Patients with Cognitive Impairment: A Randomized Clinical Trial. International Journal of Community Based Nursing & Midwifery. 2018;6(3):197–208. [PMC free article] [PubMed] [Google Scholar]
  • 43.Sekhar MS, Unnikrishnan MK, Vijayanarayana K, Rodrigues GS. Impact of Patient-Education on Health Related Quality of Life of Diabetic Foot Ulcer Patients: A Randomized Study. Clinical epidemiology and global health. 2019;7(3):382–8. [Google Scholar]
  • 44.Arora E, Shenoy S, Sandhu JS. Effects of Resistance Training on Metabolic Profile of Adults with Type 2 Diabetes. Indian J Med Res. 2009;129(5):515–9. [PubMed] [Google Scholar]
  • 45.Shahsavari A, Estebsari F, Atashzadeh-Shoorideh F, Ilkhani M. The Effect of Peer Support on Quality of Life among Type 2 Diabetic Patients in Deprived Areas in Iran: A Randomized Clinical Trial. Journal of education and health promotion. 2021;10(1). doi: 10.4103/jehp.jehp_72_21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Jamshidpour B, Bahrpeyma F, Khatami MR. The Effect of Aerobic and Resistance Exercise Training on the Health Related Quality of Life, Physical Function, and Muscle Strength among Hemodialysis Patients with Type 2 Diabetes. Journal of bodywork and movement therapies. 2020;24(2):98–103. doi: 10.1016/j.jbmt.2019.10.003 [DOI] [PubMed] [Google Scholar]
  • 47.Abraham AM, Sudhir PM, Philip M, Bantwal G. Efficacy of a Brief Self-Management Intervention in Type 2 Diabetes Mellitus: A Randomized Controlled Trial from India. Indian journal of psychological medicine. 2020;42(6):540–8. doi: 10.1177/0253717620932250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Rias YA, Kurniawan AL, Chang CW, Gordon CJ, Tsai HT. Synergistic Effects of Regular Walking and Alkaline Electrolyzed Water on Decreasing Inflammation and Oxidative Stress, and Increasing Quality of Life in Individuals with Type 2 Diabetes: A Community Based Randomized Controlled Trial. Antioxidants. 2020;9(10). doi: 10.3390/antiox9100946 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Peimani M, Monjazebi F, Ghodssi-Ghassemabadi R, Nasli-Esfahani E. A Peer Support Intervention in Improving Glycemic Control in Patients with Type 2 Diabetes. Patient education and counseling. 2018;101(3):460–6. doi: 10.1016/j.pec.2017.10.007 [DOI] [PubMed] [Google Scholar]
  • 50.Tapehsari BS, Alizadeh M, Khamseh ME, Seifouri S, Nojomi M. Physical Activity and Quality of Life in People with Type 2 Diabetes Mellitus: A Randomized Controlled Trial. International journal of preventive medicine. 2020;11(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Anderson RM, Funnell MM, Aikens JE, Krein SL, Fitzgerald JT, Nwankwo R, et al. Evaluating the Efficacy of an Empowerment-Based Self-Management Consultant Intervention: Results of a Two-Year Randomized Controlled Trial. Education Therapeutique du Patient / Therapeutic Patient Education. 2009;1(1):3–11. doi: 10.1051/tpe/2009002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Nouripour F, Mazloom Z, Fararouei M, Zamani A. Effect of Protein and Carbohydrate Distribution among Meals on Quality of Life, Sleep Quality, Inflammation, and Oxidative Stress in Patients with Type 2 Diabetes: A Single-Blinded Randomized Controlled Trial. Food science & nutrition. 2021;9(11):6176–85. doi: 10.1002/fsn3.2570 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Sunil Kumar D, Prakash B, Subhash Chandra BJ, Kadkol PS, Arun V, Thomas JJ. An Android Smartphone-Based Randomized Intervention Improves the Quality of Life in Patients with Type 2 Diabetes in Mysore, Karnataka, India. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(5):1327–32. [DOI] [PubMed] [Google Scholar]
  • 54.Nazir SUR, Hassali MA, Saleem F, Haque N. Medication Management Program: Adherence, Disease-Related Knowledge, Health-Related Quality of Life, and Glycemic Control for Type 2 Diabetes Mellitus. Alternative therapies in health and medicine. 2020;26:4–10. [PubMed] [Google Scholar]
  • 55.Arovah NI, Kushartanti BMW, Washington TL, Heesch KC. Walking with Diabetes (Ww-Diab) Programme a Walking Programme for Indonesian Type 2 Diabetes Mellitus Patients: A Pilot Randomised Controlled Trial. Sage open medicine. 2018;6. doi: 10.1177/2050312118814391 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Mash RJ, Rhode H, Zwarenstein M, Rollnick S, Lombard C, Steyn K, et al. Effectiveness of a Group Diabetes Education Programme in under-Served Communities in South Africa: A Pragmatic Cluster Randomized Controlled Trial. Diabetic medicine. 2014;31(8):987–93. doi: 10.1111/dme.12475 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Lyu QY, Huang JW, Li YX, Chen QL, Yu XX, Wang JL, et al. Effects of a Nurse Led Web-Based Transitional Care Program on the Glycemic Control and Quality of Life Post Hospital Discharge in Patients with Type 2 Diabetes: A Randomized Controlled Trial. International Journal of Nursing Studies. 2021;119:103929. doi: 10.1016/j.ijnurstu.2021.103929 [DOI] [PubMed] [Google Scholar]
  • 58.Wattana C, Srisuphan W, Pothiban L, Upchurch SL. Effects of a Diabetes Self-Management Program on Glycemic Control, Coronary Heart Disease Risk, and Quality of Life among Thai Patients with Type 2 Diabetes. Nursing & health sciences. 2007;9(2):135–41. doi: 10.1111/j.1442-2018.2007.00315.x [DOI] [PubMed] [Google Scholar]
  • 59.Zuo XW, Dong ZM, Zhang P, Zhang P, Chang GQ, Xiang QY, et al. Effects of Cognitive Behavioral Therapy on Sleep Disturbances and Quality of Life among Adults with Type 2 Diabetes Mellitus: A Randomized Controlled Trial. Nutrition metabolism and cardiovascular diseases. 2020;30(11):1980–8. doi: 10.1016/j.numecd.2020.06.024 [DOI] [PubMed] [Google Scholar]
  • 60.Butt M, Ali AM, Bakry MM, Mustafa N. Impact of a Pharmacist Led Diabetes Mellitus Intervention on Hba1c, Medication Adherence and Quality of Life: A Randomised Controlled Study. Saudi pharmaceutical journal. 2016;24(1):40–8. doi: 10.1016/j.jsps.2015.02.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Castillo-Hernandez KG, Laviada-Molina H, Hernandez-Escalante VM, Molina-Segui F, Mena-Macossay L, Caballero AE. Peer Support Added to Diabetes Education Improves Metabolic Control and Quality of Life in Mayan Adults Living with Type 2 Diabetes: A Randomized Controlled Trial. Canadian journal of diabetes. 2021;45(3):206–13. doi: 10.1016/j.jcjd.2020.08.107 [DOI] [PubMed] [Google Scholar]
  • 62.Cheng L, Sit JWH, Choi K-c, Chair S-y, Li X, Wu Y, et al. The Effects of an Empowerment-Based Self-Management Intervention on Empowerment Level, Psychological Distress, and Quality of Life in Patients with Poorly Controlled Type 2 Diabetes: A Randomized Controlled Trial. International Journal of Nursing Studies. 2021;116. doi: 10.1016/j.ijnurstu.2019.103407 [DOI] [PubMed] [Google Scholar]
  • 63.Yucel H, Uysal O. Pilates-Based Mat Exercises and Parameters of Quality of Life in Women with Type 2 Diabetes. Iranian red crescent medical journal. 2018;20. [Google Scholar]
  • 64.Umphonsathien M, Rattanasian P, Lokattachariya S, Suansawang W, Boonyasuppayakorn K, Khovidhunkit W. Effects of Intermittent Very-Low Calorie Diet on Glycemic Control and Cardiovascular Risk Factors in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial. Journal of diabetes investigation. 2022;13(1):156–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Chaveepojnkamjorn W, Pichainarong N, Schelp FP, Mahaweerawat U. A Randomized Controlled Trial to Improve the Quality of Life of Type 2 Diabetic Patients Using a Self-Help Group Program. Southeast asian journal of tropical medicine and public health. 2009;40(1):169–76. [PubMed] [Google Scholar]
  • 66.Browning C, Chapman A, Yang H, Liu S, Zhang T, Enticott JC, et al. Management of Type 2 Diabetes in China: The Happy Life Club, a Pragmatic Cluster Randomised Controlled Trial Using Health Coaches. BMJ Open. 2016;6(3):e009319. doi: 10.1136/bmjopen-2015-009319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Akinci B, Yeldan I, Satman I, Dirican A, Ozdincler AR. The Effects of Internet-Based Exercise Compared with Supervised Group Exercise in People with Type 2 Diabetes: A Randomized Controlled Study. Clinical rehabilitation. 2018;32(6):799–810. doi: 10.1177/0269215518757052 [DOI] [PubMed] [Google Scholar]
  • 68.Jaipakdee J, Jiamjarasrangsi W, Lohsoonthorn V, Lertmaharit S. Effectiveness of a Self-Management Support Program for Thais with Type 2 Diabetes: Evaluation According to the Re-Aim Framework. Nursing & health sciences. 2015;17(3):362–9. [DOI] [PubMed] [Google Scholar]
  • 69.Wongrochananan S, Tuicomepee A, Buranarach M, Jiamjarasrangsi W. The Effectiveness of Interactive Multi-Modality Intervention on Self-Management Support of Type 2 Diabetic Patients in Thailand: A Cluster-Randomized Controlled Trial. International journal of diabetes in developing countries. 2015;35:S230–S6. [Google Scholar]
  • 70.Cani CG, Lopes LDG, Queiroz M, Nery M. Improvement in Medication Adherence and Self-Management of Diabetes with a Clinical Pharmacy Program: A Randomized Controlled Trial in Patients with Type 2 Diabetes Undergoing Insulin Therapy at a Teaching Hospital. Clinics. 2015;70(2):102–6. doi: 10.6061/clinics/2015(02)06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Shi M, Liu ZL, Zhu YB, Xu MY, Duan XY, Shi HM, et al. Effect of Health Education Based on Integrative Therapy of Chinese and Western Medicine for Adult Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study. Chinese journal of integrative medicine. 2018;24(2):94–102. doi: 10.1007/s11655-015-2113-6 [DOI] [PubMed] [Google Scholar]
  • 72.Kong JX, Zhu L, Wang HM, Li Y, Guo AY, Gao C, et al. Effectiveness of the Chronic Care Model in Type 2 Diabetes Management in a Community Health Service Center in China: A Group Randomized Experimental Study. Journal of diabetes research. 2019;2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Safavi M, Samadi N, Mahmoodi M. Effect of Quality of Life Improvement on Type 2 Diabetes Patients’ Self-Esteem. Saudi medical journal. 2011;32(9):953–7. [PubMed] [Google Scholar]
  • 74.Yang L, Xu J, Kang C, Bai Q, Wang X, Du S, et al. Effects of Mobile Phone–Based Telemedicine Management in Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial. American Journal of the Medical Sciences. 2022;363(3):224–31. doi: 10.1016/j.amjms.2021.09.001 [DOI] [PubMed] [Google Scholar]
  • 75.Dede ND, İpekci SH, Kebapcılar L, Arslan M, Kurban S, Yıldız M, et al. Influence of Exercise on Leptin, Adiponectin and Quality of Life in Type 2 Diabetics. Tip 2 diyabetlilerde egzersizin leptin, adiponektin ve yaşam kalitesi Üzerine etkisi. 2015;19(1):7–13. [Google Scholar]
  • 76.Kumar DS, Prakash B, Chandra BJS, Kadkol PS, Arun V, Thomas JJ. An Android Smartphone-Based Randomized Intervention Improves the Quality of Life in Patients with Type 2 Diabetes in Mysore, Karnataka, India. Diabetes & metabolic syndrome-clinical research & reviews. 2020;14(5):1327–32. [DOI] [PubMed] [Google Scholar]
  • 77.Miri SF, Javadi M, Lin CY, Griffiths MD, Bjork M, Pakpour AH. Effectiveness of Cognitive-Behavioral Therapy on Nutrition Improvement and Weight of Overweight and Obese Adolescents: A Randomized Controlled Trial. Diabetes & metabolic syndrome-clinical research & reviews. 2019;13(3):2190–7. [DOI] [PubMed] [Google Scholar]
  • 78.Aminuddin HB, Jiao N, Jiang Y, Hong J, Wang W. Effectiveness of Smartphone-Based Self-Management Interventions on Self-Efficacy, Self-Care Activities, Health-Related Quality of Life and Clinical Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. International Journal of Nursing Studies. 2021;116:103286. doi: 10.1016/j.ijnurstu.2019.02.003 [DOI] [PubMed] [Google Scholar]
  • 79.Cochran J, Conn VS. Meta-Analysis of Quality of Life Outcomes Following Diabetes Self-Management Training. The Diabetes educator. 2008;34(5):815–23. doi: 10.1177/0145721708323640 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Rosiek A, Kornatowski T, Frąckowiak-Maciejewska N, Rosiek-Kryszewska A, Wyżgowski P, Leksowski K. Health Behaviors of Patients Diagnosed with Type 2 Diabetes Mellitus and Their Influence on the Patients’ Satisfaction with Life. Ther Clin Risk Manag. 2016;12:1783–92. doi: 10.2147/TCRM.S118014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Boulé NG, Kenny GP, Haddad E, Wells GA, Sigal RJ. Meta-Analysis of the Effect of Structured Exercise Training on Cardiorespiratory Fitness in Type 2 Diabetes Mellitus. Diabetologia. 2003;46(8):1071–81. doi: 10.1007/s00125-003-1160-2 [DOI] [PubMed] [Google Scholar]
  • 82.Kazukauskiene N, Podlipskyte A, Varoneckas G, Mickuviene N. Health-Related Quality of Life and Insulin Resistance over a 10-Year Follow-Up. Sci Rep. 2021;11(1):24294. doi: 10.1038/s41598-021-03791-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Rosli NA, Mazapuspavina MY, Ismail Z, Elkudssiah Ismail N. Relationship of Self Efficacy in Medication Understanding with Quality of Life among Elderly with Type 2 Diabetes Mellitus on Polypharmacy in Malaysia. Int J Environ Res Public Health. 2022;19(5). doi: 10.3390/ijerph19053031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Walker RJ, Smalls BL, Hernandez-Tejada MA, Campbell JA, Egede LE. Effect of Diabetes Self-Efficacy on Glycemic Control, Medication Adherence, Self-Care Behaviors, and Quality of Life in a Predominantly Low-Income, Minority Population. Ethn Dis. 2014;24(3):349–55. doi: 10.1093/pubmed/fdr107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Wilson D, Parsons J, Tucker G. The Sf-36 Summary Scales: Problems and Solutions. Soz Praventivmed. 2000;45(6):239–46. doi: 10.1007/BF01591686 [DOI] [PubMed] [Google Scholar]
  • 86.Tucker G, Adams R, Wilson D. Observed Agreement Problems between Sub-Scales and Summary Components of the Sf-36 Version 2—an Alternative Scoring Method Can Correct the Problem. Plos one. 2013;8(4):e61191. doi: 10.1371/journal.pone.0061191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Lins L, Carvalho FM. Sf-36 Total Score as a Single Measure of Health-Related Quality of Life: Scoping Review. SAGE Open Med. 2016;4:2050312116671725. doi: 10.1177/2050312116671725 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Dahal PK, Hosseinzadeh H. Association of Health Literacy and Diabetes Self-Management: A Systematic Review. Aust J Prim Health. 2019;25(6):526–33. doi: 10.1071/PY19007 [DOI] [PubMed] [Google Scholar]
  • 89.Cunningham AT, Crittendon DR, White N, Mills GD, Diaz V, LaNoue MD. The Effect of Diabetes Self-Management Education on Hba1c and Quality of Life in African-Americans: A Systematic Review and Meta-Analysis. BMC Health Services Research. 2018;18(1):367. doi: 10.1186/s12913-018-3186-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Quimby KR, Sobers N, George C, Greaves N, Browman-Jones F, Samuels TA. Implementation of a Community-Based Low-Calorie Dietary Intervention for the Induction of Type-2 Diabetes and Pre-Diabetes Remission: A Feasibility Study Utilising a Type 2 Hybrid Design. Implementation Science Communications. 2021;2(1):95. doi: 10.1186/s43058-021-00196-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Johnston BC, Kanters S, Bandayrel K, Wu P, Naji F, Siemieniuk RA, et al. Comparison of Weight Loss among Named Diet Programs in Overweight and Obese Adults: A Meta-Analysis. Jama. 2014;312(9):923–33. doi: 10.1001/jama.2014.10397 [DOI] [PubMed] [Google Scholar]
  • 92.Presley B, Groot W, Pavlova M. Pharmacy-Led Interventions to Improve Medication Adherence among Adults with Diabetes: A Systematic Review and Meta-Analysis. Res Social Adm Pharm. 2019;15(9):1057–67. doi: 10.1016/j.sapharm.2018.09.021 [DOI] [PubMed] [Google Scholar]
  • 93.Akobeng AK. Understanding Randomised Controlled Trials. Archives of Disease in Childhood. 2005;90(8):840. doi: 10.1136/adc.2004.058222 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Edward Zimbudzi

2 Jun 2023

PONE-D-23-05175The effect of health behavior interventions to manage Type 2 diabetes on the quality of life in low-and middle-income countries: a systematic review and meta-analysisPLOS ONE

Dear Dr. Karki,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 Please submit your revised manuscript by Jul 17 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Edward Zimbudzi

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for asking me to perform this review. I hope that my comments and suggestions can help the authors improve the reporting of their review, and strengthen the synthesis and conclusions/interpretations.

1. Background: The statement using reference 5 seems inflated without any mention of its context eg high income countries or such. Findings from what appears to be a similar review to this (Ref 13) seem to be crucial for providing rationale for this review; perhaps describe how/why findings were inconclusive and/or any other limitations of that review or the eligible studies. The reviews from the Middle East and West Pacific should be described as only including studies from the respective countries (if this is true) to enhance the rational for this current (broader scope) review. Line 79, I think “reviews” not “studies” are limited?

2. The primary outcome is described (in several places) as the “change in QOL scores between the intervention and control arms”, but should be described as the difference between arms in the change scores. I would encourage the authors to run a post hoc subgroup analysis comparing findings between generic and disease-specific overall QOL scales because these can capture quite different domains/concepts and disease-specific scores may be more sensitive to intervention effects. Further, if effects are similar between groups this may reduce the limitations mentioned for use of so many measurement tools.

3. Were only studies that reported QOL outcomes included, for example if a study protocol stated that they measured the outcome but there is no report of the findings were they excluded? If this is the case for any studies I would encourage the authors to include those studies and account for this potential reporting bias/missing data. It is somewhat concerning that only studies having pre and post measurement of QOL (ie for change scores) were included and the limitations of this should be noted. When reviewing RCTs it is usually thought that change scores are not required/superior since baseline imbalances should be minimal. Some rationale for this criteria should be mentioned.

4. Please include the date of the searches and whether there were any date limits for eligibility (in abstract and methods section). If at all feasible within word limits, in the abstract mention that data extraction was single reviewer with verification and that risk of bias (preferable term to quality assessment) assessment was conducted in duplicate. In then the results section of the main text, please mention and (in an appendix) include a list of excluded full texts; this can be limited to the ones potentially most relevant to the topic if necessary. Tables 2 and 3 could be moved to an appendix, with the addition to Table 1 of the QOL scale(s) used by each study; Table 1 could be sorted by one or more logical factors, such as alphabetic names, study date, types of intervention etc., with an indication of this method in the text or table header/title. In Table 3, I’m not sure the data from subscales is useful since it wasn’t synthesized in any manner in the review.

5. What did the authors do if QOL was measured at more than one time point post-intervention? Do the author think that post-intervention follow-up duration is variable enough (as was intervention duration) do run any analysis on this?

6. For quality assessment/risk of bias, i) allocation to study groups occurs before the intervention is delivered can always be concealed, ii) the (in)feasibility of blinding participants to their group (after allocation) does not mean that there is no risk for bias – the ratings should be lowered for lack of participant blinding, especially for a review of patient-reported outcomes. The lack of blinding may be lessened to some degree in studies with wait-list or attention controls, if these existed. What does appropriate trial design mean? Also, if the review authors essentially re-analyzed the study authors data (i.e. not relying on the trial authors adjusted analysis etc) they should not use (or heavily weigh) the authors’ analysis as criteria for their own assessment. The assessments should be used in the review synthesis to some extent (see below on possibly sensitivity analysis). The results section has very little description apart from loss to follow-up related to the risk of bias across studies, and does not mention where to find the full assessments.

7. It is assumed that the control groups were all usual care/no intervention, but this should be stated in the study eligibility. In some cases the usual care group (in our experience with chronic diseases) can closely align with one of the interventions of interest to the review. The authors should describe the usual care arms, as able, across the studies and consider if there needs to be any sensitivity analysis or study exclusions based on these.

8. Analysis: Current methods guidance for systematic reviews supports sensitivity analysis for methodological decisions of the review authors (e.g. use of one vs another type of analysis, need to impute variance measures from other studies in the review when they are missing from one or more studies) or concerns about study reporting or eligibility (e.g. uncertain eligibility of an intervention, high risk of bias), rather than based on the study results as is done in this review for their influencer and outlier analysis – for which the possible cause of any changes to the effect estimate are not interpretable. I would encourage the authors to consider removing their influencer and outlier analyses and focus on review or study-level variables that may explain the heterogeneity. They could add sensitivity analysis for risk of bias (removing high ROB studies) and possibly from use of a different correlation coefficient for their calculations of SDs for change scores (as Cochrane handbook recommends). The methods section does not describe what covariates (including whether they were categorical or continuous) were used for meta-regressions; it also does not mention that intervention duration (< vs > 12 weeks) was used for subgroup analysis.

9. Please describe in the results section why there were 14 studies excluded from the meta-analysis, presumably because only subscales of QOL tools were reported? If there were other reasons such as missing variance measures, these can be dealt with by imputing values from other studies and running sensitivity analysis.

10. Interpretation: The findings from the subgroup analysis of delivery setting are heavily overstated in the abstract and main text conclusions. In the abstract conclusions, the authors should likely state that “may substantially improve” or similar, to impart the effect size, rather than just mentioning “significance”. It is unfortunate that the authors did not assess certainty of the evidence (using GRADE or similar) which may have changed some of their conclusions (e.g. “borderline” significant findings for the PCS may have been interpreted differently i.e. possibly a moderate effect size with limitations/reduced certainty due to imprecision and/or inconsistency [causing the wide CI]; risk of bias more integrated into their interpretations if indeed this made any difference to findings). If this is not possible, adding a couple sensitivity (e.g. risk of bias) and subgroup (eg type of QOL scale) may allow for more comment on the robustness of the results and discussion on the specific limitations. Systematic reviews usually use duplicate full text screening and the lack of this should be mentioned in the limitations section.

Reviewer #2: Thank you authors for doing a great job on the manuscript. Kindly respond to comments made especially on the methodology section. Again, specify which systematic review methodology you followed. Is it according to JBI format or ?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer comments.pdf

PLoS One. 2023 Oct 16;18(10):e0293028. doi: 10.1371/journal.pone.0293028.r002

Author response to Decision Letter 0


17 Jul 2023

Editor’s comments:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

We thank the editors for this comment. We have revised our manuscript aligning with the style requirements of PLOS One. We have named our files aligning with the file naming requirement of PLOS One.

2. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

We thank the editors for this comment. The “data not provided” phrase in the manuscript has been removed. (please see page 28, line 237)

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

We thank the editors for this comment. We have now moved the ethics statement to the Method section of the manuscript. Please see page 6 lines 100-101. The statement reads as follows:

“Ethical approval was not required for conducting this systematic review and meta-analysis.”

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

We thank the editors for this comment. We have now included the captions for our supporting information files at the end of our manuscript under the heading “Supporting information” (please see page 45 lines 770-789) and updated the in-text citations to match accordingly.

Reviewers’ comments

Reviewer #1: Thank you for asking me to perform this review. I hope that my comments and suggestions can help the authors improve the reporting of their review, and strengthen the synthesis and conclusions/interpretations.

1. Background: The statement using reference 5 seems inflated without any mention of its context eg high income countries or such. Findings from what appears to be a similar review to this (Ref 13) seem to be crucial for providing rationale for this review; perhaps describe how/why findings were inconclusive and/or any other limitations of that review or the eligible studies. The reviews from the Middle East and West Pacific should be described as only including studies from the respective countries (if this is true) to enhance the rational for this current (broader scope) review. Line 79, I think “reviews” not “studies” are limited?

Thank you so much for your thoughtful comments. As advised, we have revised the background section, and added the context of the finding (please see page 4, lines 57-59). The revised statement now reads as follows:

“Furthermore, improved QOL is significantly associated with improved diabetes self-management as shown by a review of studies mostly conducted in high income countries (HICs).”

Similarly, we have revised the background section describing why findings in relation to QOL were inconclusive in the study by Flood et. al (ref 13) (please see page 4, lines 61-65). The revised paragraph now reads as follows:

“Previous reviews from LMICs have shown the effectiveness of DSME on metabolic parameters [6, 12], however, outcomes in relation to QOL are inconclusive due to limited data availability on QOL outcomes [13]. This paucity of data due to the complex construct of QOL combined with likely measurement error makes the assessment of QOL really challenging [14].”

The reviews from the Middle East and West Pacific have been described as reviews of studies conducted in either LMICs or HICs. Similarly, we have also stated the limitations of previous reviews in the revised manuscript to enhance the rational of our review (please see page 4-5, lines 65-75). The revised paragraph now reads as follows:

“A review of twelve studies, conducted in four LMICs and two HICs indicated that DSME interventions were effective in improving clinical parameters as well as patient-reported outcomes such as self-management behavior, QOL and self-efficacy [15]. Similarly, another review of eight studies, conducted in five HICs and three LMICs demonstrated QOL improvement in 3 out of the 5 randomized controlled trials (RCTs) that reported change in QOL measures [16]. However, these reviews only included studies with DSME components, and excluded studies solely focussing on other health behaviour interventions such as structured dietary and/or exercise programs. In addition, these reviews have not been synthesized to produce a pooled estimate of the effect size, which is critical to strengthen the existing evidence base. Moreover, there is a dearth of reviews exclusively focusing on LMICs.”

The sentence on line 73 (originally line 79) has been revised to suggest “reviews”, not “studies” (please see page 5, line 73). The sentence now reads as follows:

“In addition, these reviews have not been synthesized to produce a pooled estimate of the effect size, which is critical to strengthen the existing evidence base. Moreover, there is a dearth of reviews exclusively focusing on LMICs.

2. The primary outcome is described (in several places) as the “change in QOL scores between the intervention and control arms”, but should be described as the difference between arms in the change scores. I would encourage the authors to run a post hoc subgroup analysis comparing findings between generic and disease-specific overall QOL scales because these can capture quite different domains/concepts and disease-specific scores may be more sensitive to intervention effects. Further, if effects are similar between groups this may reduce the limitations mentioned for use of so many measurement tools.

Thank you so much for the comment. We have now replaced “Change in QOL” with “difference in QOL change scores between the intervention and control groups” as the primary outcome of the review throughout the manuscript. The revised sentences now read as follows:

“Difference in QOL change scores between the intervention and control group was calculated as the standardized mean difference (SMD) of QOL scores observed between the intervention and control groups.” (page 2 line 27-29)

“The primary outcome measure of this review was difference in QOL change scores between the intervention and control groups.” (page 8 line 147-148)

We conducted subgroup analyses based on QOL scales and have added to the methods section (please see page 10, line 201-205). The statement reads as follows:

“Subgroup analyses were performed to investigate differences in the effect of behavior change intervention on QOL scores based on intervention type (DSME, diet and/or physical activity interventions), and settings (hospital/diabetes clinic, community health centere, home/web-based), intervention duration (less than 12 weeks, 12 weeks or longer), QOL scale (generic, disease-specific), and methodology quality (good, fair, poor).”

We have added the findings from sub-group analyses to the results section (please see page 31, line 302-304). The added findings read as follows:

“Subgroup analyses based on types of QOL scales did not suggest significant differences in QOL between studies that used generic scale compared to those that used diabetes-specific scale (Q=0.80, p-value=0.37).”

Subgroup analysis based on QOL scales for PCS and MCS was not possible because all studies involved used a generic QOL scale. We have added this to the supplementary table (S6 Table) footnote.

3. Were only studies that reported QOL outcomes included, for example if a study protocol stated that they measured the outcome but there is no report of the findings were they excluded? If this is the case for any studies I would encourage the authors to include those studies and account for this potential reporting bias/missing data. It is somewhat concerning that only studies having pre and post measurement of QOL (ie for change scores) were included and the limitations of this should be noted. When reviewing RCTs it is usually thought that change scores are not required/superior since baseline imbalances should be minimal. Some rationale for this criteria should be mentioned.

Thank you for pointing this out. We did not see any protocols that stated they measured the outcome but didn’t report the findings. We acknowledge that there might be some degree of reporting bias in the literature as previous studies suggest that reporting bias does occur in QOL literature (1, 2). Therefore, we have now highlighted this as a limitation of the study (please see page 37 line 453-455). In this review, our objective was to ascertain the effect of the health behaviour intervention on QOL as the primary outcome, therefore, by design, we reviewed both the pre-and post-intervention QOL scores and the effect therein of the intervention on the study-assessed QOL outcomes (either post-intervention QOL scores compared against control or simply changes in QOL scores post-intervention). The revised limitation sub-section reads as follows:

“Similarly, the potential of reporting bias in the included RCTs may have influenced the findings of our review.”

4. Please include the date of the searches and whether there were any date limits for eligibility (in abstract and methods section). If at all feasible within word limits, in the abstract mention that data extraction was single reviewer with verification and that risk of bias (preferable term to quality assessment) assessment was conducted in duplicate. In then the results section of the main text, please mention and (in an appendix) include a list of excluded full texts; this can be limited to the ones potentially most relevant to the topic if necessary. Tables 2 and 3 could be moved to an appendix, with the addition to Table 1 of the QOL scale(s) used by each study; Table 1 could be sorted by one or more logical factors, such as alphabetic names, study date, types of intervention etc., with an indication of this method in the text or table header/title. In Table 3, I’m not sure the data from subscales is useful since it wasn’t synthesized in any manner in the review.

We have added the date of searches and date limits in the abstract (please see page 2, lines 24-25). The revised sentence in the abstract reads as follows:

“Electronic databases PUBMED/MEDLINE, SCOPUS, CINAHL, Embase, Web of Science and PsycINFO were searched from May to June 2022. Studies published between January 2000 and May 2022, conducted in LMICs using randomized controlled trial design, using a health behavior intervention for T2DM management, and reporting QOL outcomes were included.”

Due to the abstract word limit, we couldn’t add that data extraction was done by a single reviewer and risk of bias assessment by two reviewers. However, we have presented the detailed information on assessment of risk of bias in the methods section main text field.

We have included the list of excluded full text articles with reasons in an appendix (S7 Table) and also mentioned it in the text (please see page 11 line 217-218). The added sentences read as follows:

“Altogether, 386 studies were excluded after full text review. The list of excluded articles is presented in the appendix as S7 Table.”

As per your suggestion, we have moved Table 2 and Table 3 to appendix, S2 Table and S3 Table respectively, and added a column on Table 1 presenting the QOL scales which was previously in Table 2 (please see Table 1, pages 12-28).

We have also added a column “Control detail” for providing information on what the control groups received. Table 1 has been sorted by author name in an alphabetic manner and we have indicated it in the title of the table (please see title of Table 1 on page 12, line 236).

We presented the data from QOL subscales in Table 3 although we did not synthesize the subscale data. This was done so that our readership can have an overall idea of all QOL-related data reported by all studies included in the review, not only the QOL scale data that we used in our synthesis. Many trials have presented only the domain-specific QOL data, not the composite scores (PCS and MCS) or the overall mean QOL scores, hence, to provide an overall picture of all QOL data that studies have reported, we decided to keep the data from subscales in the table (S3 Table after revision).

5. What did the authors do if QOL was measured at more than one time point post-intervention? Do the author think that post-intervention follow-up duration is variable enough (as was intervention duration) do run any analysis on this?

Thank you, we appreciate the reviewer’s comment. For studies that measured QOL at multiple time point post-intervention, we only included the post-intervention QOL measures (directly following the intervention completion). As this study aimed to investigate the effect of health behaviour intervention on QOL and to reduce the follow-up effects (lost to follow-up, changes in behaviour, etc.) and to improve the homogeneity of data extracted, no follow-up data was included in our meta-analysis. Only five studies (Azami (2018), Mohammadi (2018), Zuo (2020), Cheng (56), Abraham (2020)) reported follow up measurements with follow-up durations ranging from 13 weeks to 26 weeks post-intervention. The overall meta-analysis effect of mean QOL was not sensitive to these studies (SMD=1.89, 95% CI: 0.71 to 3.08 I2:96.8). No further analyses were feasible. This is added to Methods (please see page 10 lines 195-198):

“For studies with QOL measurements at multiple time-points, only the measurements at baseline and following intervention completion (post-intervention) were included in the meta-analysis to reduce the follow-up effect and improve homogeneity in data extraction.”

6. For quality assessment/risk of bias, i) allocation to study groups occurs before the intervention is delivered can always be concealed, ii) the (in)feasibility of blinding participants to their group (after allocation) does not mean that there is no risk for bias – the ratings should be lowered for lack of participant blinding, especially for a review of patient-reported outcomes. The lack of blinding may be lessened to some degree in studies with wait-list or attention controls, if these existed. What does appropriate trial design mean? Also, if the review authors essentially re-analyzed the study authors data (i.e. not relying on the trial authors adjusted analysis etc) they should not use (or heavily weigh) the authors’ analysis as criteria for their own assessment. The assessments should be used in the review synthesis to some extent (see below on possibly sensitivity analysis). The results section has very little description apart from loss to follow-up related to the risk of bias across studies, and does not mention where to find the full assessments.

Thank you so much for the comment.

i) Indeed, allocation concealment can always be done in RCTs. However, in 26 RCTs included in our review, there was either a clear statement of “allocation concealment not being done” or no clear indication whether allocation was concealed or not. Some of those RCTs mentioned about generating random numbers with the use of computer (allocation sequence generation) (e.g., Mash (2014), Umphonsathien (2022), Yang (2022), Shi (2018)), however, they did not mention about concealment of those allocation sequences, hence, the allocation concealment for those RCTs have been rated as unclear (please see S4 Table in the appendix). Three RCTs clearly stated that allocation concealment was not done in their full texts (Abraham (2020), Arovah (2018), and Saghaee (2020)).

ii) Since the type of intervention used in the RCTs included in our review are health behavior interventions to manage Type 2 diabetes, blinding of participants or study personnel wouldn’t have been generally feasible in the RCTs due to the involvement of participants and/or personnel in the behavioral interventions (3), hence we did not downgrade for those risks/uncertainties (4). Appropriate trial design means the design of the RCTs included in the review were appropriate for the objective of the study. For example, if an RCT is aiming to assess the effectiveness of DSME intervention in improving QOL of people with T2DM, then the appropriate RCT design would be parallel-group RCT or cluster RCT, but not crossover RCT (5). All RCTs included in our review followed appropriate trial design.

We have updated the results section to include clearer information on risk of bias within studies and certainty of evidence across studies included in the meta-analyses. The revised paragraphs read as follows:

“An overview of the quality assessment of the studies is presented in the appendix as S4 Table. Allocation of study participants to intervention and control groups wasn’t concealed in three studies and not clearly indicated in 23 studies. Only two studies clearly specified blinding of participants, five stated blinding of those delivering the intervention, and 13 specified blinding of outcome assessors. Blinding of participants is generally difficult in behavioral interventions due to participants being aware whether they receive the intervention, hence studies that did not address or clarify blinding were not downgraded for those risks or uncertainties [28]. Use of appropriate trial design and statistical analysis methodology was strong in all studies. Thirty-eight studies provided information on participants’ attrition with reasons for dropouts and withdrawals. In 23 studies, the data were analysed following the intention-to-treat principle. The quality of evidence across studies included in the meta-analyses, assessed using the GRADE approach, is presented in the appendix as S5 Table, and the description is provided below, under each meta-analysis heading – “Meta-analysis of Mean QOL scores”, “Meta-analysis of Physical Component Summary Scores”, and “Meta-analysis of Mental Component Summary Scores”.” (please see page 30, lines 268-282)

“In the GRADE certainty of evidence assessment, the studies were downgraded one level each due to high heterogeneity (I2: 94%) and the presence of publication bias as seen in the funnel plot (S3 Fig). However, due to large effect size (SMD: 1.62), the studies were upgraded by one level. Overall, the GRADE certainty of evidence was classified as moderate quality (S5 Table).” (please see page 31 lines 309-312)

“Due to high heterogeneity (I2: 94%) and imprecise results (wide CI), the GRADE certainty of evidence was classified as low quality (S5 Table).” (please see page 32, lines 337-338)

“Due to high heterogeneity (I2: 94%) and imprecise results (wide CI), the GRADE certainty of evidence was classified as low quality (S5 Table).” (please see page 34 lines 362-363)

7. It is assumed that the control groups were all usual care/no intervention, but this should be stated in the study eligibility. In some cases the usual care group (in our experience with chronic diseases) can closely align with one of the interventions of interest to the review. The authors should describe the usual care arms, as able, across the studies and consider if there needs to be any sensitivity analysis or study exclusions based on these.

Thank you for the comment. The control groups were either usual care, waitlist control or attentional control. This has been stated in the main text (please see page 6 lines 106-109) and the sentence reads as follows:

“The population group was people with T2DM; intervention was any health behavioural intervention targeted at T2DM management; comparison group was usual care, waitlist or attentional control group; and study design was randomized controlled trial.”

The control groups in the studies included in the review received usual, waitlist or attentional care in relation to routine diabetes care/education/management but did not receive any component of the intervention of interest except for one study by Castillo-Hernandez et al. The influence analysis (based on one-out method) did not suggest that the overall meta-analysis results are sensitive to the study by Castillo-Hernandez et al.

We have described the usual care arm in Table 1 across the studies (please see “Control detail” column in Table 1, pages 12-28).

8. Analysis: Current methods guidance for systematic reviews supports sensitivity analysis for methodological decisions of the review authors (e.g. use of one vs another type of analysis, need to impute variance measures from other studies in the review when they are missing from one or more studies) or concerns about study reporting or eligibility (e.g. uncertain eligibility of an intervention, high risk of bias), rather than based on the study results as is done in this review for their influencer and outlier analysis – for which the possible cause of any changes to the effect estimate are not interpretable. I would encourage the authors to consider removing their influencer and outlier analyses and focus on review or study-level variables that may explain the heterogeneity. They could add sensitivity analysis for risk of bias (removing high ROB studies) and possibly from use of a different correlation coefficient for their calculations of SDs for change scores (as Cochrane handbook recommends). The methods section does not describe what covariates (including whether they were categorical or continuous) were used for meta-regressions; it also does not mention that intervention duration (< vs > 12 weeks) was used for subgroup analysis.

Thank you for the comment. Following previous literature (4), quality of the studies was rated as good (≥8), fair (6-7), or poor (≤5) based on the summary scores obtained from the critical appraisal using the JBI checklist for RCTs. Altogether 34 studies were of good quality and 11 studies of fair quality. Since no studies were of poor quality, we included all 45 studies in the review. Please see S4 Table in the appendix for the full quality assessment of the studies.

Initially, in the manuscript, we had not presented the quality (good, fair, poor) data or grading of bias in the quality assessment table because JBI checklist for RCTs does not provide any threshold for grading the bias as either low, high, moderate or others. We had rather presented the overall appraisal in the quality assessment table. To check for the need to add sensitivity analysis for risk of bias (removing high ROB studies), we have added the “Quality” column in the quality assessment table for grading the studies as good, fair or poor as mentioned above (4), and upon assessing the scores, found that no studies were of poor quality (please see S4 Table in the appendix).

We also appreciate the reviewer’s comment that changes of outliers to the meta-analysis is difficult to interpret. However, outlier analysis was an important step in our meta-analysis, especially as high heterogeneity was observed. Outliers were defined as studies that shift the direction of the effect and/or the heterogeneity of the meta-analysis. The influence of some outliers on the overall meta-analyses was observed, defined as changes in the heterogeneity. However, given that they did not impact the significance or direction of the effect, a decision was made to keep the outliers in the final meta-analysis (6).

We also agree with the reviewer’s comment that sensitivity/subgroup analysis based on risk of bias and correlation coefficient adds to the robustness of the analysis and findings. Therefore, following the reviewer’s suggestion (feedback 10), subgroup analyses based on quality of methodology of included studies were conducted and reported in S6 Table. Please refer to the authors’ response for feedback 10 for more information. We have also updated the methods section to include the following information:

“Subgroup analyses were performed to investigate differences in the effect of behavior change intervention on QOL scores based on intervention type (DSME, diet and/or physical activity interventions), and settings (hospital/diabetes clinic, community health center, home/web-based), intervention duration (less than 12 weeks, 12 weeks or longer), QOL scale (generic, disease-specific), and methodology quality (good, fair, poor).” (please see page 10, lines 201-205)

“Meta-regression analyses were performed to determine the linear relationship between duration as a continuous covariate and the effect size.” (please see page 10, lines 205-207)

Also, meta-analysis of mean QOL was performed using correlation coefficient 0.4 and 0.8 and compared to the assumed coefficient of 0.6. These analyses resulted in changes in magnitude of overall meta-analysis but did not change the direction of the effect or heterogeneity.

r = 0.4: SMD 1.44 (0.59 to 2.28), p-value=0.0008, I2=96%

r = 0.8: SMD 2.26 (1.01 to 3.50), p-value=0.0004, I2=97.3%

These analyses are provided in the appendix (S6 Table) and explained in the Methods section (page 10 line 207-209).

“Meta analyses using different correlation coefficients (r =0.8 and 0.4) were also conducted to compare the direction of effect and heterogeneity with the assumed coefficient (r = 0.6).”

and Results (page 30 lines 288-289)

“Meta-analysis using different correlation coefficient (r=0.4 and 0.8) did not change the direction of the effect or the heterogeneity (S6 Table).”

9. Please describe in the results section why there were 14 studies excluded from the meta-analysis, presumably because only subscales of QOL tools were reported? If there were other reasons such as missing variance measures, these can be dealt with by imputing values from other studies and running sensitivity analysis.

Thank you for the comment. Fourteen studies were excluded from the meta-analysis because they only reported the domain specific QOL scores but did not report on the total mean QOL score or composite (physical component summary or mental component summary) scores. We have stated this in the main text (please see page 34 lines 369-370). We have also stated this as one of the limitations of our study (please see page 37 line 452-453).

10. Interpretation: The findings from the subgroup analysis of delivery setting are heavily overstated in the abstract and main text conclusions. In the abstract conclusions, the authors should likely state that “may substantially improve” or similar, to impart the effect size, rather than just mentioning “significance”. It is unfortunate that the authors did not assess certainty of the evidence (using GRADE or similar) which may have changed some of their conclusions (e.g. “borderline” significant findings for the PCS may have been interpreted differently i.e. possibly a moderate effect size with limitations/reduced certainty due to imprecision and/or inconsistency [causing the wide CI]; risk of bias more integrated into their interpretations if indeed this made any difference to findings). If this is not possible, adding a couple sensitivity (e.g. risk of bias) and subgroup (eg type of QOL scale) may allow for more comment on the robustness of the results and discussion on the specific limitations. Systematic reviews usually use duplicate full text screening and the lack of this should be mentioned in the limitations section.

Thank you for the comment. We acknowledge that the results from the subgroup analysis of delivery setting were overstated in the abstract and main text conclusion. We have removed the emphasis on the subgroup analysis and rephrased the results section in the abstract which now read as follows:

“Of 6122 studies identified initially, 45 studies met the inclusion criteria (n=8336). Of them, 31 involved diabetes self-management education and 14 included dietary and/or physical activity intervention. There was moderate quality evidence from the meta-analysis of mean QOL (n=25) that health behavior interventions significantly improved the QOL of people with T2DM (SMD=1.62, 95%CI=0.65-2.60 I2=0.96, p=0.001). However, no significant improvements were found for studies (n=7) separately assessing the physical component summary (SMD=0.76, 95%CI= -0.03-1.56 I2=0.94, p=0.060) and mental component summary (SMD=0.43, 95%CI= -0.30-1.16 I2=0.94, p=0.249) scores. High heterogeneity and imprecise results across studies resulted in low to moderate quality of evidence.” (please see page 2-3 lines 31-39)

We have also edited the main text conclusion (please see page 38 lines 463-468) and emphasized the low to moderate quality of evidence limiting our conclusion along with the significant finding of the sub-group analysis by intervention setting. The statements read as follows:

“In conclusion, this systematic review and meta-analysis identified health behavior interventions targeted at improving T2DM management as effective strategies in improving the QOL of people with T2DM, with interventions based in community health centres likely to be more effective in improving the physical and mental health component of QOL than those based in clinical or home/web-based settings. However, the low to moderate quality of evidence limits the strength of our conclusion from the pooled evidence.”

We have changed “may significantly improve” to “may substantially improve” in the abstract conclusion (please see page 3 lines 41-42).

As stated in above responses, we have assessed the certainty of evidence across studies included in the meta-a using the GRADE approach (please see S5 Table in the appendix). According to the table, the certainty of evidence of studies included in the meta-a of mean QOL is of moderate quality whereas, the certainty of evidence of studies included in the PCS and MCS meta-a are of low quality. We have added the findings from the GRADE assessment in the results section (as stated in the above response for feedback 6) and in the conclusion (please see page 38 lines 463-468). The revised sentences in the conclusion read as follows:

“In conclusion, this systematic review and meta-analysis identified health behavior interventions targeted at improving T2DM management as effective strategies in improving the QOL of people with T2DM, with interventions based in community health centres likely to be more effective in improving the physical and mental health component of QOL than those based in clinical or home/web-based settings. However, the low to moderate quality of evidence limits the strength of our conclusion from the pooled evidence.”

We thank the reviewer for their notes on the full-text screening. Full texts of retrieved studies were screened by two reviewers (AK and PD) independently. We apologise for the writing mistake in the main text and confirm that we have corrected the sentence (please see page 7 lines 139-140), which now reads as follows:

“Full texts of retrieved studies were then screened by two reviewers (AK and PD) independently.”

We appreciate the reviewer’s comment and agree that a subgroup analysis based on methodology quality of the studies will add to the robustness of the findings. The following sections are added to the results:

“Subgroup analysis based on methodology quality of included studies resulted in a significant improvement in mean QOL in interventions that deemed to have a ‘good’ quality of methodology (n=21). Interventions with ‘fair’ method quality (n=6) did not result in a significant improvement in mean QOL (n=6). However, the test for subgroup analysis was not significant (Q=0.66, p-value=0.41) (S6 Table).” (please see page 31 lines 304-308)

“Subgroup analysis of overall PCS scores based on methodology quality of included studies was not different between studies that deemed to have a ‘good’ methodology quality (n=7) compared to the one study that had a fair methodology quality (S6 Table).” (please see page 32 lines 331-334)

“Subgroup analysis of overall MCS scores based on methodology quality of included studies was not different between studies that deemed to have a ‘good’ methodology quality (n=7) compared to the one study that had a fair methodology quality (S6 Table).” (please see page 33 lines 356-359)

Reviewer #2: Thank you authors for doing a great job on the manuscript. Kindly respond to comments made especially on the methodology section. Again, specify which systematic review methodology you followed. Is it according to JBI format or ?

Thank you for the comment. We have responded to all comments made by the reviewers. We are grateful to have received such constructive feedback and sincerely believe this feedback have greatly helped in improving the quality of the manuscript. We followed the Joanna Briggs Institute (JBI) systematic review methodology and have stated this in the manuscript too (please see page 6 lines 96-98). The statement in the manuscript reads as follows:

“This systematic review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guideline [21] and followed the Joanna Briggs Institute (JBI) systematic review methodology [22].”

Abstract

Background

Limited research has assessed this effect in low and middle-income countries (LMICs), nor has it been systematically reviewed. Remember, the research on this area is available but the synthesis of the research done to this effect is limited.

Thank you for your thoughtful comment. We have now revised the sentence and it reads as follows:

“Limited reviews have synthesized this effect in low- and middle-income countries (LMICs)” (please see page 2 lines 18-19)

Methods

• Was there a timeline for this review?

• Which methodology did you follow? Is it the JBI systematic review methodology?

Thank you for the comment. We started the review with preliminary literature search and review in April 2022; developed the review protocol and submitted to PROSPERO for registration; conducted the systematic search and review using COVIDENCE; synthesised the evidence; reported the findings and prepared a manuscript for publication. Overall, from formulating the research question of the review to submitting the manuscript for publication, the systematic review and meta-analysis was completed in 11 months. Due to abstract word limit, we could not add this information to the abstract, however, we have included this information in the manuscript.

“Electronic databases PUBMED/MEDLINE, SCOPUS, CINAHL, Embase, Web of Science and PsycINFO were searched from May to June 2022” (please see page 2 lines 23-24).

“Data were searched from 26 May to 1 June 2022.” (page 6 line 103)

“The articles retrieved from the search were exported to COVIDENCE [24], a web-based software developed to streamline systematic review process on 2 June 2022.” (page 7 lines 136-137)

“The study selection was completed on 22 July 2022.” (page 8 lines 142-143)

“Author name, publication year, study objective, country, setting, study design, demographic characteristics such as age, gender, etc., intervention description, control details, duration of intervention and follow up, QOL measurement tools, and primary and secondary intervention outcomes of interest were extracted using a template by one author (AK) and their accuracy were checked by the second author (PD) [25] from 23 July to 25 August 2022.” (page 8 lines 152-157)

We followed the JBI systematic review methodology and have stated it in the manuscript too (please see page 6 lines 96-98). We couldn’t add this to the abstract due to abstract word limit. The statement in the manuscript reads as follows:

“This systematic review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guideline [21] and followed the Joanna Briggs Institute (JBI) systematic review methodology [22].”

Conclusion

• What recommendation can be given based on your study results?

Based on our study results, health behaviour interventions targeted at improving T2DM management may improve quality of life in people with T2DM, however, the interpretation of our findings warrants caution due to the variability of scales used in QOL measurement and low to moderate quality of evidence generated. Therefore, further studies with standardized scales are recommended for more robust estimates. Furthermore, large and well-powered RCTs of high methodological quality are recommended to establish the effect of health behavior interventions on QOL. We have updated our conclusion in the abstract which now reads as follows:

“The findings suggest that health behavior interventions to manage T2DM may substantially improve the QOL of individuals with T2DM. However, due to low to moderate quality of evidence, further research is required to corroborate our findings. Results of this review may guide future research and have policy implications for T2DM management in LMICs.” (page 3 lines 41-44)

We have also updated the recommendation and conclusion in the main text, which reads as follows (please see page 38, lines 463-474):

“In conclusion, this systematic review and meta-analysis identified health behavior interventions targeted at improving T2DM management as effective strategies in improving the QOL of people with T2DM, with interventions based in community health centres likely to be more effective in improving the physical and mental health component of QOL than those based in clinical or home/web-based settings. However, the low to moderate quality of evidence limits the strength of our conclusion from the pooled evidence. Due to the variability of the scales used in QOL measurement and, the interpretation of our findings warrants caution. Further studies with specific standardized scales are recommended for more robust estimates. Furthermore, this review highlights the need for more well-designed RCTs of high methodological quality focusing on QOL as a primary outcome measure. The evidence generated from this review may guide future research and clinical practice and may derive policy implications for the management of T2DM in LMICs.”

Key words

• Rather say health behaviour intervention

• Randomised control trial is not a key word, kindly remove it

Thank you for the suggestion. Following the journal guideline, we have not added any keywords in the manuscript. However, in the online submission system, we have included “health behaviour intervention” and removed “randomised control trial” as keywords.

Introduction

Remember, this is not primary research. You are looking at synthesis of the available studies whether they are few or not. Therefore, your motivation for the review should not be based on this.

Thank you for the comment. I agree with the reviewer’s suggestion and have made necessary revision. The sentence now reads as follows:

“In sum, studies worldwide have shown that health behavior interventions are effective in optimising glycemic control and diabetes management [12, 19]. However, despite QOL being an important measure in T2DM management, the synthesis of evidence on the effect of these interventions on the QOL of people with T2DM in LMICs is limited.” (please see page 5 lines 85-88)

Methodology

Data sources and searches

• This systematic review adhered to the Preferred Reporting Items for Systematic

Reviews and Meta-Analysis (PRISMA) guideline [20]. The review protocol was

registered in the PROSPERO International Prospective Register of systematic reviews

(Registration ID 90 CRD42022323184). Give a subheading to this section as Reporting and registration of the review. Also give a date when the protocol was registered.

Thank you for the comment. We have added the subheading “Reporting and registration of the review” (please see page 6 line 95). We have also added the date of protocol registration as 5 July 2022 (please see page 6 line 100)

• Kindly add the date for the data searches, how long did it last?

• Online databases PUBMED/MEDLINE, SCOPUS, CINAHL, Embase, Web of Science and

PsycINFO were searched using the pre-defined search terms. How did you come out with the predefined search terms? Did you use PICO/PIO?

• A manual search of reference lists of included studies was also conducted to identify

additional studies that met the inclusion criteria. What determined your inclusion and exclusion criteria? This needs to be covered maybe separately so that it becomes clearer to the readers.

Thank you for the comment. Data were searched from 26 May to 1 June 2022. The search terms were built using PICOS framework, which we have added to the main text as well. The revised sentences now read as follows:

“Data were searched from 26 May to 1 June 2022. Online databases PUBMED/MEDLINE, SCOPUS, CINAHL, Embase, Web of Science and PsycINFO were searched using the pre-defined search terms, which were based on the PICOS (population, intervention, comparison, outcome, and study design) framework. The population group was people with T2DM; intervention was any health behavioural intervention targeted at T2DM management; comparison group was usual care, waitlist or attentional control group; and study design was randomized controlled trial.” (please see page 6 lines 103-109)

Our inclusion and exclusion criteria are reported separately under the sub-heading “Inclusion and exclusion criteria” as per the reviewer’s suggestion (please see page 7, line 119-134)

Then data was extracted only from the RCTs conducted in LMICs. Why are you talking of data extraction at this stage of searching in data bases? Whatever you search in data bases is taken to a systematic review app (either covidence or Ryann) before you even start of selection and extraction.

• How did the authors define the LMIC? How many countries make up the LMIC?

Thank you for the comment. We have removed the sentence “The data was extracted only from the RCTs conducted in LMICs” from the “Data sources and searches” paragraph and included the sentence in the “Data extraction” paragraph (please see page 8 line 152).

We defined LMIC adopting the definition of the World Bank (7) and have included this information in the main text (please see page 7 lines 129-130). According to the World Bank, “For the current fiscal year 2023, low-income economies are defined as those having a Gross national income per capita of $1085 or less in 2021; lower middle-income economies are those with a GNI per capita between $1086 and $4255; and upper middle-income economies are those with a GNI per capita between $4256 and $13,205”. Altogether, 136 countries make up the LMIC.

Study selection

•Only studies with an RCT design were included in this review to ensure that the

evidence 103 provided on the effectiveness of interventions was robust. When

multiple articles from the 104 same study/studies were found, only the article that

reported the most relevant QOL 105 information/outcome was included. All types of

health behavior interventions were included 106 regardless of the setting. Only studies

conducted between January 2000 and May 2022 and published in English language

were included in the review, as examining QOL in individuals with T2DM is a relatively

new concept. Studies were included if they 1) examined any behavioral or educational

interventions targeted at improving T2DM management among people with new or

established diagnosis of T2DM; 2) reported QOL outcomes using validated 111 QOL

measures, both pre- and post-intervention, as a primary or secondary outcome; 3)

were conducted within an RCT design; and 4) were conducted in LMICs [21]. Studies

were excluded if they 1) were published in languages other than English; 2) had

therapeutic or pharmacological intervention strategies; 3) had mixed study population

of Type 1 and 2 diabetes with no separate data reported for T2DM population; 4) were

observational studies or reported in reviews, editorials, theses, books, short

communication; or 5) presented inadequate or unclear QOL data. This is the inclusion

and exclusion criteria which should be presented separately.

Thank you for the comment. We have reported our inclusion and exclusion criteria under a separate heading “Inclusion and exclusion criteria” (please see page 7, lines 118-134).

• Selection of articles should start after all the selected articles from the data bases are in Covidence. Once in Covidence, you start with duplicate removal. After duplicate removal, outline the selection based on abstract and title first, then full text screening.

Thank you for the comment. We have moved the heading “Study selection” further down in the manuscript which now contains information as suggested by the reviewer, that is, export of retrieved articles to COVIDENCE, duplicates removal, title and abstract screening and full-text screening (please see page 7-8, lines 135-143).

• Full texts of retrieved studies were then screened by the first reviewer (AK). Why the full text screening done by one reviewer? Because two reviewers are supposed to do independently with blind on, then solve the disagreements later.

Thank you for pointing this out. We apologise for the writing mistake in the main text. Full texts of retrieved studies were screened by two reviewers (AK and PD) independently. Both title, abstract and full text were screened by two reviewers (AK and PD) independently. We have corrected the sentence in the manuscript which now reads as follows:

“Full texts of retrieved studies were then screened by two reviewers (AK and PD) independently.” (please see page 7 lines 139-140)

• Any disagreements were resolved through consultation with other team members. What type of disagreements were resolved or were there any?

Thank you for the comment. The following type of disagreements were resolved through consensus among team members. There was a disagreement between two authors (AK and PD) on whether to keep RCTs evaluating a mix of pharmacological and non-pharmacological (e.g. health behaviours) intervention (8) or multi arm trials with both health behaviour intervention and pharmacological intervention (9). Disagreements were then resolved through consultation with other team members and a decision was made to exclude those RCTs that had a mix of health behaviour and pharmacological intervention (as it was difficult to ascertain the intervention effect in multi arm trials).

• Add the selection dates, how long did the selection take?

The selection dates are from 2 June 2022 (import of references to COVIDENCE) to 22 July 2022 (completion of full text screening). Hence, the study selection took seven weeks. We have added the study selection dates in the manuscript (please see page 7, line 137 and page 8, line 143).

Data Extraction

• Kindly add the dates for the data extraction

Thank you for the suggestion. The dates of the data extraction are from 23 July 2022 to 25 August 2022. These dates are added in the manuscript too (please see page 8, line 157).

References

1. Didsbury MS, Kim S, Medway MM, Tong A, McTaggart SJ, Walker AM, et al. Socio-economic status and quality of life in children with chronic disease: A systematic review. J Paediatr Child Health. 2016;52(12):1062-9.

2. Fielding S, Ogbuagu A, Sivasubramaniam S, MacLennan G, Ramsay CR. Reporting and dealing with missing quality of life data in RCTs: has the picture changed in the last decade? Qual Life Res. 2016;25(12):2977-83.

3. Younge JO, Kouwenhoven-Pasmooij TA, Freak-Poli R, Roos-Hesselink JW, Hunink MM. Randomized study designs for lifestyle interventions: a tutorial. International Journal of Epidemiology. 2015;44(6):2006-19.

4. John JR, Jani H, Peters K, Agho K, Tannous WK. The Effectiveness of Patient-Centred Medical Home-Based Models of Care versus Standard Primary Care in Chronic Disease Management: A Systematic Review and Meta-Analysis of Randomised and Non-Randomised Controlled Trials. Int J Environ Res Public Health. 2020;17(18).

5. Joanna Briggs Institute. Critical Appraisal Tools 2017 [Available from: https://jbi.global/critical-appraisal-tools.

6. Baker R, Jackson D. A new approach to outliers in meta-analysis. Health Care Manag Sci. 2008;11(2):121-31.

7. The World Bank. World Bank Country and Lending Groups 2022 [Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.

8. Tu Q, Xiao LD, Ullah S, Fuller J, Du H. A transitional care intervention for hypertension control for older people with diabetes: A cluster randomized controlled trial. J Adv Nurs. 2020;76(10):2696-708.

9. Halperin F, Ding SA, Simonson DC, Panosian J, Goebel-Fabbri A, Wewalka M, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014;149(7):716-26.

Attachment

Submitted filename: Response to Reviewers comments.docx

Decision Letter 1

Edward Zimbudzi

15 Aug 2023

PONE-D-23-05175R1The effect of health behavior interventions to manage Type 2 diabetes on the quality of life in low-and middle-income countries: a systematic review and meta-analysisPLOS ONE

Dear Dr. Karki,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

As you will see from Reviewer 1's comments, there is room to improve the revised version of the manuscript to ensure that conclusions drawn from the paper closely reflect the data.

Please submit your revised manuscript by Sep 29 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Edward Zimbudzi

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed many of the suggestions from the previous peer review. I still believe that there can be more improvements to ensure current review methodology is followed and that the conclusions about the findings closely reflect the data.

Major comments:

1. I strongly object to using lack of feasibility of blinding as a reason to not rate the studies at risk of bias from lack of blinding. There is still the risk of bias regardless of blinding not being practical. This is commonly mentioned at training workshops to avoid doing. The authors may not think the risk is that serious to potentially rate down during GRADE, but the risk of bias from lack of blinding does exist.

2. The main text conclusions paragraph still mentions that the community setting is "likely" an impact on PCS and MCS findings, and this should be downplayed substantially.

3. Now that the authors have clarified that their results represent the immediate effects after the interventions, they should add the caveat that their findings are for the short-term QOL of participants and that that any lasting/sustained effect was not examined in this review. I think the term "follow-up effect" (not too sure if that is a used term) should be removed with focus that the authors chose to keep things consistent across studies using a similar timepoint.

Minor:

abstract: suggest to remove "significant" in the sentence about the mean QOL findings.

methods: delete the first sentence in the data extraction section (this refers to eligibility criteria); was <=5 or <=6 used for GRADE study limitations domain? This seems inconsistent with the risk of bias categories; please mention that the added subgroups for study quality and measurement tool were added post hoc (after protocol).

results: are the findings for the overall QOL analysis SMD 1.46 or 1.62? this has changed since the original submission and is not consistent throughout the paper.

I had hoped that the authors would have removed the "influencer" and outlier analyses, which are not current practice due to their focusing on results rather than clinical and methodological differences between studies, and would encourage them to reconsider this. The fact that these analyses did not impact the findings is not a good reason to keep them in the paper. We do not just remove/exclude a study because of it's findings being "different" from others, unless there is a methodological or clinical reason to do so. What if they study was actually the best conducted and largest??

Lastly I think the authors could consider focusing on the (moderate certainty) overall QOL findings and speak to these a bit more strongly as indicating benefit at least over the short term. One recommendation may be for more longer term follow-up to see if the effects are sustainable.

Thank you

Reviewer #2: Thank you authors for addressing the comments raised. Congratulations on the job well done and this has improved the quality of the manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Oct 16;18(10):e0293028. doi: 10.1371/journal.pone.0293028.r004

Author response to Decision Letter 1


27 Aug 2023

The Editor-in-Chief

PLOS One

Subject: Submission of revised manuscript on “The effect of health behavior interventions to manage Type 2 diabetes on the quality of life in low-and middle-income countries: a systematic review and meta-analysis”

Thank you for providing us with the opportunity to submit a revised manuscript “The effect of health behavior interventions to manage Type 2 diabetes on the quality of life in low-and middle-income countries: a systematic review and meta-analysis” for consideration of publication in PLOS One.

We express our gratitude to the reviewers for providing feedback and their insightful comments on the manuscript, which certainly have helped to enhance the quality of the manuscript. We would like to confirm that the reference list is complete and correct and no retracted papers have been cited.

Please find a point-by-point response to the editor’s and reviewers’ comments below. Author’s responses are marked blue. All page and line numbers refer to the track changed version of the revised manuscript.

Reviewer #1: The authors have addressed many of the suggestions from the previous peer review. I still believe that there can be more improvements to ensure current review methodology is followed and that the conclusions about the findings closely reflect the data.

Thank you for your thoughtful comment. We have addressed all your comments.

Major comments:

1. I strongly object to using lack of feasibility of blinding as a reason to not rate the studies at risk of bias from lack of blinding. There is still the risk of bias regardless of blinding not being practical. This is commonly mentioned at training workshops to avoid doing. The authors may not think the risk is that serious to potentially rate down during GRADE, but the risk of bias from lack of blinding does exist.

Thank you for the comment. Upon further consideration and discussion with the co-authors, we agree with the reviewer and acknowledge that the lack of blinding poses a risk of bias in behavioral interventions regardless of whether blinding was feasible or not. Hence, studies not reporting blinding of either the participants, personnel or outcome assessors were given a score of “0” and marked as “N” for “No” under the respective items about blinding of participants, personnel or outcome assessors in the 13-item Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Randomized Controlled Trials. We have detailed out all this information in the Quality Assessment section under Methods and results both, as following (please see pages 8-9, lines 160-180):

In Methods:

“The 13-item Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Randomized Controlled Trials was used to assess methodological quality of the selected studies [26]. Two reviewers (AK and PD) independently assessed the risk of bias. Any disagreements were discussed with the team members until consensus was reached. Each item in the JBI checklist was scored one if they fulfilled the criteria for that item and scored zero if they did not fulfil the criteria. For example, if a study reported blinding of outcome assessors, then the study was scored ‘1’ for the item about blinding of outcome assessors, whereas, if the study did not report blinding of outcome assessors, then the study was scored ‘0’. Summary scores were obtained for each selected studies by adding the item-specific scores. The quality of the studies was then rated as good (≥8), fair (6-7), or poor (≤5) based on the summary scores [27]. In addition, the quality of evidence across RCTs included in the meta-analysis was assessed by two reviewers (AK and PD) using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, and rated as high, moderate, low or very low [28]. Since all included studies were RCTs, the rating began with a high-certainty rating. Then, the quality was upgraded or downgraded based on the following criteria: i) quality across the studies as determined by the JBI Critical Appraisal Checklist for Randomized Controlled Trials; ii) inconsistency/heterogeneity level; iii) indirectness of evidence; iv) imprecise results (wide 95% CI i.e., > 0.8 SMD); and v) publication bias (visual inspection of funnel plot) [29]. If the majority of the RCTs scored ≤ 5 on the JBI scale, the certainty of evidence was downgraded two places whereas, if the effect size was large (SMD ≥ 0.8), then the evidence was upgraded one place [29].”

From the Results section, we have removed the statement “Blinding of participants is generally difficult in behavioral interventions due to participants being aware whether they receive the intervention, hence studies that did not address or clarify blinding were not downgraded for those risks or uncertainties.” (page 31, lines 283-286). We have also added a description in the Results section, which read as follows:

“The overall quality of the studies ranged from “fair” to “good” after obtaining a summary score of at least six in the quality assessment. No study was rated as poor quality as none obtained a summary score of five or less.” (please see page 31, lines 278-280)

2. The main text conclusions paragraph still mentions that the community setting is "likely" an impact on PCS and MCS findings, and this should be downplayed substantially.

We thank the reviewer for noting this. We have removed the statement about community setting having an impact on the PCS and MCS findings. The removed statement is in page 39 lines 480-482 of the track changed document.

3. Now that the authors have clarified that their results represent the immediate effects after the interventions, they should add the caveat that their findings are for the short-term QOL of participants and that that any lasting/sustained effect was not examined in this review. I think the term "follow-up effect" (not too sure if that is a used term) should be removed with focus that the authors chose to keep things consistent across studies using a similar timepoint.

Thank you for this comment. Since we measured the immediate post-intervention effects of the interventions and didn’t measure the longer-term effect of the interventions, we have added it as one of the limitations of the study in page 38-39 lines 466-469. The statement now reads as follows:

“Thirdly, the findings of this meta-analysis only related to short-term QOL (i.e., immediate post-intervention effects) and any lasting/sustained effect was not examined in this review as there was no sufficient data to examine longer-term effects on QOL.”

We have removed the term “follow-up effect” and revised the statement, which now reads as follows (page 10 lines 202-206):

“For studies with QOL measurements at multiple time-points, only the measurements at baseline and following intervention completion (post-intervention) were included in the meta-analysis to maintain consistency across studies using a similar timepoint and improve homogeneity in data extraction.”

Minor:

abstract: suggest to remove "significant" in the sentence about the mean QOL findings.

Thank you for the comment. The word “significant” has been removed from the statement, which now reads as below (please see page 2, line 34):

“There was moderate quality evidence from the meta-analysis of mean QOL (n=25) that health behavior intervention improved the QOL of people with T2DM (SMD=1.62, 95%CI=0.65-2.60 I2=0.96, p=0.001).”

methods: delete the first sentence in the data extraction section (this refers to eligibility criteria); was <=5 or <=6 used for GRADE study limitations domain? This seems inconsistent with the risk of bias categories; please mention that the added subgroups for study quality and measurement tool were added post hoc (after protocol).

Thank you for the comment. The first sentence from the data extraction section in the manuscript body, which initially read as “Data was extracted only from the RCTs conducted in LMICs” has been removed. (see page 8, line 153)

≤5 was used as the GRADE study limitation domain to be consistent with the risk of bias categories. We have corrected the inconsistencies and replaced ≤6 with ≤5. The sentence now reads as below (please see page 9, lines 177-180):

“If the majority of the RCTs scored ≤5 on the JBI scale, the certainty of evidence was downgraded two places whereas, if the effect size was large (SMD ≥ 0.8), then the evidence was upgraded one place [29].”

We have added a statement about performing post-hoc subgroup analyses based on study quality and QOL scale, which reads as follows:

“Sub-group analyses based on QOL scale and methodology quality were added post hoc.” (see page 10 lines 213-214)

results: are the findings for the overall QOL analysis SMD 1.46 or 1.62? this has changed since the original submission and is not consistent throughout the paper.

Thank you for the comment. The correct SMD is 1.62. We have made necessary correction at page 32-33 line 323-324). The corrected sentence now reads as follows:

“However, due to large effect size (SMD: 1.62), the studies were upgraded by one level.”

I had hoped that the authors would have removed the "influencer" and outlier analyses, which are not current practice due to their focusing on results rather than clinical and methodological differences between studies, and would encourage them to reconsider this. The fact that these analyses did not impact the findings is not a good reason to keep them in the paper. We do not just remove/exclude a study because of it's findings being "different" from others, unless there is a methodological or clinical reason to do so. What if they study was actually the best conducted and largest??

Thank you for the comment. We have removed the “influence” and “outlier” analyses as suggested by the reviewer. We have removed all the following texts in relation to influence and outlier analyses from the manuscript:

“Outliers were identified statistically and graphically.” (page 10, line 199)

“Sensitivity analyses were performed using a leave-one-out method, where individual trials are excluded one at a time and the changes in overall results and heterogeneity are explored.” (page 10, lines 207-208)

“Influence analyses (S2 Fig) suggested that the overall meta-analysis was sensitive to the study by Safavi et al (74). Excluding this study did not change the direction of the effect (SMD: 1.17, 95% CI: 0.70 to 1.64, I2: 0.95).” (page 32, lines 303-305)

“Outlier analysis identified nine studies as outliers [8, 46, 48, 50, 52, 55, 61, 63, 74]. Excluding these studies reduced the heterogeneity slightly (to 90.1%) and the magnitude but not the overall direction of the effect (SMD: 1.14, 95% CI: 0.83 to 1.45, p-value<0.001).” (page 33, lines 326-328)

“Influence analyses (S4 Fig) suggested that the overall meta-analysis was sensitive to the study by Rias et al. [49]. Excluding this study did not change the direction or the significance of the effect (SMD: 0.458, 95% CI: -0.125 to 1.040, I2: 0.922).” (page 33, lines 336-338)

“Outlier analysis identified two studies as outliers [44, 49]. Excluding these studies reduced the heterogeneity to 0% and resulted in an overall significant effect (SMD 0.18, 95% CI: 0.03 to 0.34, p-value<0.05).” (page 34, lines 352-354)

“Influence analyses (S6 Fig) suggested that the overall meta-analysis was sensitive to the study by Sekhar et al. [44]. However, excluding this study did not change the direction or the significance of the effect (SMD: 0.094, 95% CI: -0.349 to 0.537, I2: 0.883).” (page 34, lines 361-363)

“Two studies were identified as outliers in the outlier analysis [44, 73]. Excluding these studies reduced the heterogeneity to 72.4% but not the overall direction of the effect (SMD 0.24, 95% CI: -0.17 to 0.65, p-value<0.256).” (page 35, lines 377-379)

We have also removed the supporting information caption of sensitivity analyses, which initially read as below:

“S2 Fig. Sensitivity analysis of Mean Quality of life” (page 47 line 790)

“S4 Fig. Sensitivity analysis of Mean Physical Component Summary” (page 47 line 792)

“S6 Fig. Sensitivity analysis of mean Mental Component Summary” (page 47 line 795)

Lastly, I think the authors could consider focusing on the (moderate certainty) overall QOL findings and speak to these a bit more strongly as indicating benefit at least over the short term. One recommendation may be for more longer term follow-up to see if the effects are sustainable.

Thank you for this comment. We have rephrased the main text conclusion focusing on the moderate certainty of evidence of overall QOL findings indicating benefits over at least short period of time. The revised conclusion reads as follows (please see page 39-40 lines 478-493):

“In conclusion, this systematic review and meta-analysis identified health behavior interventions targeted at improving T2DM management as effective strategies in improving the QOL of people with T2DM. The study demonstrated a moderate certainty of evidence for the overall QOL findings, indicating that the immediate post-intervention improvement on the overall QOL of people with T2DM is likely to be close to the true effect of the interventions on QOL over the short term. However, the low quality of evidence of PCS and MCS findings limits the strength of our conclusion from the pooled evidence. Due to the variability of the scales used in QOL measurement, the interpretation of our findings warrants caution. Studies with specific standardized scales are recommended for more robust estimates. Further research is needed to examine the long-term effectiveness of health behavior interventions on QOL. Furthermore, this review highlights the need for more well-designed RCTs of high methodological quality focusing on QOL as a primary outcome measure. The evidence generated from this review may guide future research and clinical practice and may derive policy implications for the management of T2DM in LMICs.”

We have added a recommendation about the need for conducting further studies assessing the longer-term effects of the interventions; the statement reads as follows (see page 39 lines 489-490):

“Further research is needed to examine the long-term effectiveness of health behaviour interventions on QOL.”

Reviewer #2: Thank you authors for addressing the comments raised. Congratulations on the job well done and this has improved the quality of the manuscript.

Thank you. We appreciate the valuable feedback from the reviewers.

Attachment

Submitted filename: Response to Reviewers comments.docx

Decision Letter 2

Edward Zimbudzi

4 Oct 2023

The effect of health behavior interventions to manage Type 2 diabetes on the quality of life in low-and middle-income countries: a systematic review and meta-analysis

PONE-D-23-05175R2

Dear Dr. Karki,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Edward Zimbudzi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Acceptance letter

Edward Zimbudzi

8 Oct 2023

PONE-D-23-05175R2

The effect of health behavior interventions to manage Type 2 diabetes on the quality of life in low-and middle-income countries: a systematic review and meta-analysis

Dear Dr. Karki:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Edward Zimbudzi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA checklist.

    (DOC)

    S1 Fig. R codes used in the meta-analysis.

    (DOCX)

    S2 Fig. Funnel plot of Mean QOL.

    (DOCX)

    S3 Fig. Funnel plot of Mean Physical Component Summary.

    (DOCX)

    S4 Fig. Funnel plot of Mean Mental Component Summary.

    (DOCX)

    S1 Table. Detailed search strategy.

    (DOCX)

    S2 Table. Intervention characteristics of studies included in the review sorted alphabetically by author.

    (DOCX)

    S3 Table. Effect of health behavior intervention on the primary (quality of life) and secondary outcomes.

    (DOCX)

    S4 Table. Quality assessment of studies using Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Randomized Controlled Trials.

    (DOCX)

    S5 Table. GRADE certainty of evidence.

    (DOCX)

    S6 Table. Subgroup analyses.

    (DOCX)

    S7 Table. List of studies excluded during full-text screening.

    (DOCX)

    Attachment

    Submitted filename: Reviewer comments.pdf

    Attachment

    Submitted filename: Response to Reviewers comments.docx

    Attachment

    Submitted filename: Response to Reviewers comments.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES